View Filing Data

Print Document View Excel Document

Document and Entity Information	3 Months Ended
Document and Entity Information	Sep. 30, 2012 shares
Document and Entity Information [Abstract]
Entity Registrant Name	IMAX Corporation
Entity Central Index Key	0000921582
Document Type	10-Q
Document Period End Date	Sep. 30, 2012
Amendment Flag	false
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Well Known Seasoned Issuer	Yes
Entity Voluntary Filers	Yes
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock Shares Outstanding	65,977,319

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Assets
Cash and cash equivalents	$ 29,450	$ 18,138
Accounts receivable, net of allowance for doubtful accounts of $1,636 (December 31, 2011 - $1,840)	36,147	46,659
Financing receivables (notes 3 and 17(c))	91,533	86,714
Inventories (note 4)	20,841	19,747
Prepaid expenses	4,081	3,126
Film assets	3,488	2,388
Property, plant and equipment (note 5)	109,115	101,253
Other assets (notes 9(d), 17(d) and 17(e))	25,480	14,238
Deferred income taxes (note 13(a))	40,164	50,033
Goodwill	39,027	39,027
Other intangible assets (note 6)	27,709	24,913
Total assets	427,035	406,236
Liabilities
Bank indebtedness (note 7)	30,000	55,083
Accounts payable	15,389	28,985
Accrued and other liabilities (notes 8(a), 8(c), 9, 14(b), 16(a), 16(c) and 17(d))	63,405	54,803
Deferred revenue	79,660	74,458
Total liabilities	188,454	213,329
Commitments, contingencies and guarantees (notes 8 and 9)
Shareholders' equity
Capital stock (note 14) common shares - no par value. Authorized - unlimited number. Issued and outstanding - 65,977,319 (December 31, 2011 - 65,052,740)	310,105	303,395
Other equity	26,587	17,510
Deficit	(97,008)	(125,666)
Accumulated other comprehensive loss	(1,103)	(2,332)
Total shareholders' equity	238,581	192,907
Total liabilities and shareholders' equity	$ 427,035	$ 406,236

Condensed Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Assets
Allowance for doubtful accounts	$ 1,636	$ 1,840
Shareholders' equity
Common stock, share issued	65,977,319	65,052,740
Common stock, share outstanding	65,977,319	65,052,740

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Revenues
Equipment and product sales	$ 24,327	$ 18,378	$ 55,756	$ 58,359
Services (note 10(c))	40,316	35,104	102,312	80,371
Rentals (note 10(c))	14,013	11,350	42,912	25,416
Finance income	2,055	1,581	5,537	4,409
Other	0	1,075	0	1,325
Revenues	80,711	67,488	206,517	169,880
Costs and expenses applicable to revenues
Equipment and product sales (note 10(a))	10,652	8,083	27,727	28,595
Services (notes 10(a) and 10(c))	21,107	19,113	55,378	48,015
Rentals (note 10(a))	4,202	3,468	12,968	9,478
Other	0	386	0	406
Cost and expenses applicable to revenues, total	35,961	31,050	96,073	86,494
Gross margin	44,750	36,438	110,444	83,386
Selling, general and administrative expenses (note 10(b)) (including share-based compensation expense of $2.8 million and $10.3 million for the three and nine months ended September 30, 2012, respectively (2011 - expense of $0.5 million and $9.0 million, respectively))	19,326	19,440	58,713	55,778
Provision for arbitration award (note 9(c))	0	0	0	2,055
Research and development	2,528	2,041	7,623	6,026
Amortization of intangibles	166	113	532	341
Receivable provisions, net of recoveries (note 12)	241	408	829	767
Asset impairments	0	8	0	8
Impairment of available-for-sale investment (note 17(b))	0	0	150	0
Income from operations	22,489	14,428	42,597	18,411
Interest income	22	13	73	44
Interest expense	(373)	(431)	(1,375)	(1,425)
Income from operations before income taxes	22,138	14,010	41,295	17,030
Provision for income taxes	(6,814)	(5,179)	(11,599)	(6,504)
Loss from equity-accounted investments	(334)	(439)	(1,038)	(1,312)
Net income	$ 14,990	$ 8,392	$ 28,658	$ 9,214
Net income per share - basic and diluted: (note 14(c))
Net income per share - basic	$ 0.23	$ 0.13	$ 0.44	$ 0.14
Net income per share - diluted	$ 0.22	$ 0.12	$ 0.42	$ 0.14

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Condensed Consolidated Statements of Operations [Abstract]
Compensation costs	$ 2.8	$ 0.5	$ 10.3	$ 9.0

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References + Details

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Comprehensive Income [Abstract]
Net income	$ 14,990	$ 8,392	$ 28,658	$ 9,214
Amortization of defined benefit plan actuarial loss (note 16(a))	91	53	273	161
Unrealized net (loss) gain from cash flow hedging instruments (note 17(d))	589	(1,151)	826	(800)
Realization of cash flow hedging net loss (gain) upon settlement (note 17(d))	(158)	(229)	(22)	(953)
Change in market value of available-for-sale investment (note 17(b))	0	0	338	(488)
Other-than-temporary impairment of available-for-sale investment (note 17(b))	0	0	150	0
Other comprehensive income (loss), before tax	522	(1,327)	1,565	(2,080)
Income tax (expense) recovery allocated to other comprehensive income (loss) (note 13(b))	(134)	352	(336)	488
Comprehensive income	$ 15,378	$ 7,417	$ 29,887	$ 7,622

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net income	$ 28,658	$ 9,214
Adjustments to reconcile net income to cash from operations:
Depreciation and amortization (note 11(c))	24,704	18,020
Write-downs, net of recoveries (note 11(d))	1,516	841
Change in deferred income taxes	9,545	5,694
Stock and other non-cash compensation	10,781	9,595
Provision for arbitration award (note 9(c))	0	2,055
Unrealized foreign currency exchange gain	(152)	4,270
Loss from equity-accounted investments	1,038	1,312
Gain on non-cash contribution to equity-accounted investees	0	(404)
Investment in film assets	(13,508)	(8,814)
Changes in other non-cash operating assets and liabilities (note 11(a))	(8,672)	(48,192)
Net cash provided by (used in) operating activities	53,910	(6,409)
Investing Activities
Purchase of property, plant and equipment	(2,599)	(4,409)
Investment in joint revenue sharing equipment	(15,174)	(22,432)
Investment in new business ventures	(381)	(1,571)
Acquisition of other intangible assets	(5,046)	(4,008)
Net cash used in investing activities	(23,200)	(32,420)
Financing Activities
Increase in bank indebtedness	9,917	59,583
Repayment of bank indebtedness	(35,000)	(37,500)
Credit facility amendment fees paid	0	(297)
Common shares issued - stock options exercised (note 14(d))	5,831	5,635
Net cash provided by financing activities	(19,252)	27,421
Effects of exchange rate changes on cash	(146)	(139)
Increase (decrease) in cash and cash equivalents during the period	11,312	(11,547)
Cash and cash equivalents, beginning of period	18,138	30,390
Cash and cash equivalents, end of period	$ 29,450	$ 18,843

Basis of Presentation

9 Months Ended

Sep. 30, 2012

Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]

Basis of Presentation

IMAX Corporation, together with its wholly-owned subsidiaries (the “Company”), reports its results under United States Generally Accepted Accounting Principles (“U.S. GAAP”).

The condensed consolidated financial statements include the accounts of the Company together with its wholly-owned subsidiaries, and any entities which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. The nature of the Company's business is such that the results of operations for the interim periods presented are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments necessary to make the results of operations for the interim periods a fair statement of such operations.

The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”). The Company has 9 film production companies that are VIEs. For two of the Company's film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE's economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. The Company continues to consolidate these entities, with no material impact on the operating results or financial condition of the Company, as these production companies have total assets and total liabilities of $nil as at September 30, 2012 (December 31, 2011 — $nil). For the other 7 film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at September 30, 2012, these 7 VIEs have total assets and total liabilities of $14.8 million (December 31, 2011 — $12.7 million). Earnings of the investees included in the Company's condensed consolidated statement of operations amounted to $nil and $nil for the three and nine months ended September 30, 2012, respectively (2011 — $nil and $nil, respectively). The carrying value of these investments in VIEs that are not consolidated is $nil at September 30, 2012 (December 31, 2011 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the condensed consolidated statement of operations. The Company's exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $0.3 million at September 30, 2012.

The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) and ASC 320 − “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate. At September 30, 2012, the equity method of accounting is being utilized for an investment with a carrying value of $3.4 million (December 31, 2011 − $4.1 million). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at its fair value of $1.3 million at September 30, 2012 (December 31, 2011 – $1.0 million). This investment is classified as an available-for-sale investment. The total carrying value of investments in new business ventures at September 30, 2012 and December 31, 2011, is $4.7 million and $5.1 million, respectively, and is recorded in Other Assets.

All significant intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.

The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

These interim financial statements should be read in conjunction with the consolidated financial statements included in the Company's 2011 Annual Report on Form 10-K for the year ended December 31, 2011 (“the 2011 Form 10-K”) which should be consulted for a summary of the significant accounting policies utilized by the Company. These interim financial statements are prepared following accounting policies consistent with the Company's financial statements for the year ended December 31, 2011, except as noted below.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6228881-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7668296&loc=d3e288-107754

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

New Accounting Standards and Accounting Changes

9 Months Ended

Sep. 30, 2012

New Accounting Standards and Accounting Changes [Abstract]

New Accounting Standards and Accounting Changes

Changes in Accounting Policies

In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (ASC Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” (“ASU 2011-04”). The standards set forth in ASU 2011-04 supersede most of the accounting guidance currently found in Topic 820 of the FASB's ASC. The amendments will improve comparability of fair value measurements presented and disclosed in financial statements prepared with U.S. GAAP and International Financial Reporting Standards (“IFRS”). The amendments also clarify the application of existing fair value measurement requirements. These amendments include (1) the application of the highest and best use and valuation premise concepts, (2) measuring the fair value of an instrument classified in a reporting entity's shareholders' equity and (3) disclosing quantitative information about the unobservable inputs used within the Level 3 hierarchy. For public entities, the amendments are effective for interim and annual periods beginning after December 15, 2011 on a prospective basis. Early application by public entities is not permitted. On January 1, 2012, the Company adopted the disclosure requirements amendments in ASU 2011-04 relating to Level 3 fair value measurements and accordingly, has expanded disclosures as presented in note 17(b).

Recently Issued FASB Accounting Standard Codification Updates

In December 2011, the FASB issued ASU No. 2011-11, “Balance Sheet - Disclosures about Offsetting Assets and Liabilities (ASC Topic 210)”. The purpose of the amendment is to provide greater clarity within disclosures between entities reporting in U.S. GAAP versus IFRS that have offsetting (netting) assets and liabilities. Entities will be required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. An entity is required to apply the amendments in ASU 2011-11 for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. It is to be applied retrospectively for all comparative periods presented. The Company is currently evaluating the potential impact of ASU 2011-11 on its condensed consolidated financial statements.

- Definition

The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.

+ References + Details

Financing Receivables

9 Months Ended

Sep. 30, 2012

Financing Receivables [Abstract]

Financing Receivables

3. Financing Receivables

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of theater systems are as follows:

	September 30,		December 31,
	2012		2011
Gross minimum lease payments receivable	$	19,340	$	29,603
Unearned finance income		(4,888)		(8,356)
Minimum lease payments receivable		14,452		21,247
Accumulated allowance for uncollectible amounts		(1,130)		(1,833)
Net investment in leases		13,322		19,414
Gross financed sales receivables		110,508		95,686
Unearned finance income		(32,231)		(28,070)
Financed sales receivables		78,277		67,616
Accumulated allowance for uncollectible amounts		(66)		(316)
Net financed sales receivables		78,211		67,300
Total financing receivables	$	91,533	$	86,714

Net financed sales receivables due within one year	$	9,851	$	8,694
Net financed sales receivables due after one year	$	68,360	$	58,606

As at September 30, 2012, the financed sale receivables had a weighted average effective interest rate of 9.1% (December 31, 2011 — 8.9%).

Inventories

9 Months Ended

Sep. 30, 2012

Inventories [Abstract]

Inventories

4. Inventories

	September 30,		December 31,
	2012		2011
Raw materials	$	7,409	$	5,803
Work-in-process		1,226		1,515
Finished goods		12,206		12,429
	$	20,841	$	19,747

At September 30, 2012, finished goods inventory for which title had passed to the customer and revenue was deferred amounted to $5.0 million (December 31, 2011 — $5.7 million).

Inventories at September 30, 2012 include provisions for excess and obsolete inventory based upon current estimates of net realizable value considering future events and conditions of $4.5 million (December 31, 2011 — $4.0 million).

Property Plant and Equipment

9 Months Ended

Sep. 30, 2012

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

5. Property, Plant and Equipment

		As at September 30, 2012
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components⁽¹⁾⁽²⁾	$	126,549	$	39,142	$	87,407
	Camera equipment⁽⁵⁾		4,493		4,286		207
			131,042		43,428		87,614
Assets under construction⁽³⁾			9,005		-		9,005
Other property, plant and equipment
	Land		1,593		-		1,593
	Buildings		14,633		9,724		4,909
	Office and production equipment⁽⁴⁾		23,550		18,955		4,595
	Leasehold improvements		9,715		8,316		1,399
			49,491		36,995		12,496
		$	189,538	$	80,423	$	109,115

		As at December 31, 2011
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components⁽¹⁾⁽²⁾	$	122,691	$	39,773	$	82,918
	Camera equipment⁽⁵⁾		6,355		6,088		267
			129,046		45,861		83,185
Assets under construction⁽³⁾			4,972		-		4,972
Other property, plant and equipment
	Land		1,593		-		1,593
	Buildings		14,633		9,352		5,281
	Office and production equipment⁽⁴⁾		29,220		24,772		4,448
	Leasehold improvements		9,396		7,622		1,774
			54,842		41,746		13,096
		$	188,860	$	87,607	$	101,253

__________

(1) Included in theater system components are assets with costs of $11.2 million (December 31, 2011 — $18.4 million) and accumulated depreciation of $10.1 million (December 31, 2011 — $17.8 million) that are leased to customers under operating leases.

(2) Included in theater system components are assets with costs of $111.1 million (December 31, 2011 — $100.2 million) and accumulated depreciation of $26.5 million (December 31, 2011 — $19.1 million) that are used in joint revenue sharing arrangements.

(3) Included in assets under construction are components with costs of $6.8 million (December 31, 2011 — $3.7 million) that will be utilized to construct assets to be used in joint revenue sharing arrangements.

(4) Fully amortized office and production equipment is still in use by the Company.

(5) Fully amortized camera equipment is still in use by the Company.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details

Other Intangible Assets

9 Months Ended

Sep. 30, 2012

Other Intangible Assets [Abstract]

Other Intangible Assets

6. Other Intangible Assets


	As at September 30, 2012
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	8,293	$	5,556	$	2,737
Licenses and intellectual property		19,750		1,358		18,392
Other		6,580		-		6,580
	$	34,623	$	6,914	$	27,709

	As at December 31, 2011
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	8,014	$	5,304	$	2,710
Licenses and intellectual property		19,407		254		19,153
Other		3,050		-		3,050
	$	30,471	$	5,558	$	24,913

The Company expects to amortize approximately $0.5 million of other intangible assets for the remainder of 2012 and an average of $2.0 million for each of the next 5 years, respectively. Fully amortized other intangible assets are still in use by the Company.

During the nine months ended September 30, 2012, the Company acquired $4.3 million in other intangible assets. The net book value of these other intangible assets was $4.2 million as at September 30, 2012. The weighted average amortization period for these additions was 10 years.

During the three and nine months ended September 30, 2012, the Company incurred costs of less than $0.1 million and $0.1 million, respectively, to renew or extend the term of acquired other intangible assets which were recorded in selling, general and administrative expenses (2011 – less than $0.1 million and $0.1 million, respectively).

Credit Facility

9 Months Ended

Sep. 30, 2012

Credit Facility [Abstract]

Credit Facility

On June 2, 2011, the Company amended and restated the terms of its existing senior secured credit facility (the “Prior Credit Facility”), which had been scheduled to mature on October 31, 2013. The amended and restated facility (the “Credit Facility”), with a scheduled maturity of October 31, 2015, has a maximum borrowing capacity of $110.0 million, consisting of revolving asset-based loans of up to $50.0 million subject to a borrowing base calculation (as described below) and including a sublimit of $20.0 million for letters of credit, and a revolving term loan of up to $60.0 million. The Prior Credit Facility had a maximum borrowing capacity of $75.0 million. Certain of the Company's subsidiaries serve as guarantors (the “Guarantors”) of the Company's obligations under the Credit Facility. The Credit Facility is collateralized by a first priority security interest in substantially all of the present and future assets of the Company and the Guarantors.

The terms of the Credit Facility are set forth in the Second Amended and Restated Credit Agreement (the “Credit Agreement”), dated June 2, 2011, among the Company, Wells Fargo Capital Finance Corporation (Canada), as agent, lender, sole lead arranger and sole bookrunner (“Wells Fargo”) and Export Development Canada, as lender (“EDC”, together with Wells Fargo, the “Lenders”) and in various collateral and security documents entered into by the Company and the Guarantors. Each of the Guarantors has also entered into a guarantee in respect of the Company's obligations under the Credit Facility.

The revolving asset-based portion of the Credit Facility permits maximum aggregate borrowings equal to the lesser of:

(i) $50.0 million, and

(ii) a collateral calculation based on the percentages of the book values of certain of the Company's net investment in sales-type leases, financing receivables, certain trade accounts receivable, finished goods inventory allocated to backlog contracts and the appraised values of the expected future cash flows related to operating leases and the Company's owned real property, reduced by certain accruals and accounts payable and subject to other conditions, limitations and reserve right requirements.

On June 2, 2013 any outstanding borrowings under the revolving term loan portion of the Credit Facility convert to a term loan to be repaid in accordance with the terms of the Credit Facility, any undrawn amounts under the revolving term loan are cancelled and the Company may not request any further advances under the revolving term loan.

The revolving asset-based portion and the revolving term portion of the Credit Facility bear interest, at the Company's option, at (i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo's prime rate plus a margin of 0.50% per annum. Under the Prior Credit Facility, the effective interest rate for the nine months ended September 30, 2011, for the term loan portion was 4.04% and 2.97% for the revolving portion. Under the Credit Facility, the effective interest rate for the revolving term loan portion was 2.39% and 2.41% for the three and nine months ended September 30, 2012, respectively (2011 — 2.69% and 2.59%, respectively). There was no amount drawn on the revolving asset-based portion of the Credit Facility.

The Credit Facility provides that the Company will be required to maintain a ratio of funded debt (as defined in the Credit Agreement) to EBITDA (as defined in the Credit Agreement) of not more than 2:1. The Company will also be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1.0. At all times under the terms of the Credit Facility, the Company is required to maintain minimum Excess Availability of not less than $5.0 million and minimum Cash and Excess Availability of not less than $15.0 million. These amounts were $55.0 million and $84.4 million at September 30, 2012 respectively. The Company was in compliance with all of these requirements at September 30, 2012.

The Credit Facility contains typical affirmative and negative covenants, including covenants that limit or restrict the ability of the Company and the Guarantors to: incur certain additional indebtedness; make certain loans, investments or guarantees; pay dividends; make certain asset sales; incur certain liens or other encumbrances; conduct certain transactions with affiliates and enter into certain corporate transactions.

The Credit Facility also contains customary events of default, including upon an acquisition or change of control or upon a change in the business and assets of the Company or a Guarantor that in each case is reasonably expected to have a material adverse effect on the Company or a Guarantor. If an event of default occurs and is continuing under the Credit Facility, the Lenders may, among other things, terminate their commitments and require immediate repayment of all amounts owed by the Company.

Bank indebtedness includes the following:

	September 30,		December 31,
	2012		2011

Revolving Term Loan	$	30,000	$	55,083

Total amounts drawn and available under the Credit Facility at September 30, 2012 were $30.0 million and $80.0 million, respectively (December 31, 2011 — $55.1 million and $52.0 million, respectively).

As at September 30, 2012, the Company's current borrowing capacity under the revolving asset-based portion of the Credit Facility was $50.0 million after deduction for letters of credit of $nil and the minimum Excess Availability reserve of $5.0 million (December 31, 2011 — $47.1 million) and borrowing capacity under the revolving term portion of the Credit Facility was $30.0 million.

As at September 30, 2012, the Company does not have any letters of credit and advance payment guarantees outstanding (December 31, 2011 — $3.0 million), under the Credit Facility.

In accordance with the loan agreement, the Company is obligated to make payments on the principal of the revolving term loan as follows:

2012 (three months remaining)	$	-
2013		-
2014		-
2015		30,000
2016		-
Thereafter		-
	$	30,000

Wells Fargo Foreign Exchange Facility

Within the Credit Facility, the Company is able to purchase foreign currency forward contracts and/or other swap arrangements. There is no settlement risk on its foreign currency forward contracts at September 30, 2012 as the fair value exceeded the notional value of the forward contracts. As at September 30, 2012, the Company has $20.8 million of such arrangements outstanding.

Bank of Montreal Facility

As at September 30, 2012, the Company has available a $10.0 million facility (December 31, 2011 — $10.0 million) with the Bank of Montreal for use solely in conjunction with the issuance of performance guarantees and letters of credit fully insured by EDC (the “Bank of Montreal Facility”). As at September 30, 2012, the Company has letters of credit and advance payment guarantees outstanding of $0.9 million (December 31, 2011 — $0.8 million) under the Bank of Montreal Facility.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References + Details

Commitments

9 Months Ended

Sep. 30, 2012

Commitments, Contingencies and Guarantees [Abstract]

Commitments

8. Commitments

(a) The Company's lease commitments consist of rent and equipment under operating leases. The Company accounts for any incentives provided over the term of the lease. Total minimum annual rental payments to be made by the Company as at September 30, 2012 for each of the years ended December 31, are as follows:

	Operating Leases		Capital Leases
2012 (three months remaining)	$	1,750	$	6
2013		6,584		20
2014		5,578		-
2015		1,286		-
2016		511		-
Thereafter		1,323		-
	$	17,032	$	26

Rent expense was $1.5 million and $4.6 million for three and nine months ended September 30, 2012, respectively (2011 — $1.3 million and $3.5 million, respectively) net of sublease rental of $nil and $nil, respectively (2011 — $nil and less than $0.1 million, respectively).

Recorded in the accrued liabilities balance as at September 30, 2012 is $2.6 million (December 31, 2011 — $3.5 million) related to accrued rent and lease inducements being recognized as an offset to rent expense over the term of the respective leases.

Purchase obligations under long-term supplier contracts as at September 30, 2012 were $8.3 million (December 31, 2011 — $12.9 million).

(b) As at September 30, 2012, the Company did not have any letters of credit and advance payment guarantees outstanding (December 31, 2011 — $3.0 million), under the Credit Facility. As at September 30, 2012, the Company had letters of credit and advance payment guarantees outstanding of $0.9 million as compared to $0.8 million as at December 31, 2011, under the Bank of Montreal Facility.

(c) The Company compensates its sales force with both fixed and variable compensation. Commissions on the sale or lease of the Company's theater systems are payable in graduated amounts from the time of collection of the customer's first payment to the Company up to the collection of the customer's last initial payment. At September 30, 2012, $1.9 million (December 31, 2011 —$1.3 million) of commissions have been accrued and will be payable in future periods.

Contingencies and Guarantees

9 Months Ended

Sep. 30, 2012

Commitments, Contingencies and Guarantees [Abstract]

Contingencies and Guarantees

9. Contingencies and Guarantees

The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. In accordance with the Contingencies Topic of the FASB ASC, the Company will make a provision for a liability when it is both probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has adequate provisions for any such matters. The Company reviews these provisions in conjunction with any related provisions on assets related to the claims at least quarterly and adjusts these provisions to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other pertinent information related to the case. Should developments in any of these matters outlined below cause a change in the Company's determination as to an unfavorable outcome and result in the need to recognize a material provision, or, should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on the Company's results of operations, cash flows, and financial position in the period or periods in which such a change in determination, settlement or judgment occurs.

The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.

(a) In March 2005, the Company, together with Three-Dimensional Media Group, Ltd. (“3DMG”), filed a complaint in the U.S. District Court for the Central District of California, Western Division, against In-Three, Inc. (“In-Three”) alleging patent infringement. On March 10, 2006, the Company and In-Three entered into a settlement agreement settling the dispute between the Company and In-Three. Despite the settlement reached between the Company and In-Three, co-plaintiff 3DMG refused to dismiss its claims against In-Three. Accordingly, the Company and In-Three moved jointly for a motion to dismiss the Company's and In-Three's claims. On August 24, 2010, the Court dismissed all of the claims pending between the Company and In-Three, thus dismissing the Company from the litigation.

On May 15, 2006, the Company initiated arbitration against 3DMG before the International Centre for Dispute Resolution in New York (the “ICDR”), alleging breaches of the license and consulting agreements between the Company and 3DMG. On June 15, 2006, 3DMG filed an answer denying any breaches and asserting counterclaims that the Company breached the parties' license agreement. On June 21, 2007, the ICDR unanimously denied 3DMG's Motion for Summary Judgment filed on April 11, 2007 concerning the Company's claims and 3DMG's counterclaims. The proceeding was suspended on May 4, 2009 due to failure of 3DMG to pay fees associated with the proceeding. The proceeding was further suspended on October 11, 2010 pending resolution of reexamination proceedings currently pending involving one of 3DMG's patents. The Company will continue to pursue its claims vigorously and believes that all allegations made by 3DMG are without merit. The Company further believes that the amount of loss, if any, suffered in connection with the counterclaims would not have a material impact on the financial position or results of operations of the Company, although no assurance can be given with respect to the ultimate outcome of the arbitration.

(b) In January 2004, the Company and IMAX Theatre Services Ltd., a subsidiary of the Company, commenced an arbitration seeking damages before the International Court of Arbitration of the International Chambers of Commerce (the “ICC”) with respect to the breach by Electronic Media Limited (“EML”) of its December 2000 agreement with the Company. In June 2004, the Company commenced a related arbitration before the ICC against EML's affiliate, E-City Entertainment (I) PVT Limited (“E-City”), seeking damages as a result of E-City's breach of a September 2000 lease agreement. An arbitration hearing took place in November 2005 against E-City which considered all claims by the Company. On February 1, 2006, the ICC issued an award on liability finding unanimously in the Company's favor on all claims. Further hearings took place in July 2006 and December 2006. On August 24, 2007, the ICC issued an award unanimously in favor of the Company in the amount of $9.4 million, consisting of past and future rents owed to the Company under its lease agreements, plus interest and costs. In the award, the ICC upheld the validity and enforceability of the Company's theater system contract. The Company thereafter submitted its application to the arbitration panel for interest and costs. On March 27, 2008, the arbitration panel issued a final award in favor of the Company in the amount of $11.3 million, plus an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid, which the Company is seeking to enforce and collect in full. In July 2008, E-City commenced a proceeding in Mumbai, India seeking an order that the ICC award may not be recognized in India. The Company has opposed that application on a number of grounds and seeks to have the ICC award recognized in India. That Mumbai proceeding is still pending. On June 24, 2011, the Company commenced an application to the Ontario Superior Court of Justice for recognition of the final award. On December 2, 2011, the Ontario court issued an order recognizing the final award and requiring E-City to pay the Company $30,000 to cover the costs of the application. On January 18, 2012, the Company filed an application in New York State Supreme Court seeking recognition of the Ontario order in New York. On April 11, 2012, the New York court issued an order granting the Company's application.

(c) In June 2003, Robots of Mars, Inc. ("Robots") initiated an arbitration proceeding against the Company in California with the American Arbitration Association pursuant to arbitration provisions in two film production agreements entered into in 1994 and 1995 between Robots' predecessor-in-interest and a discontinued subsidiary of the Company (“Ridefilm”), asserting claims for breach of contract, fraud, breach of fiduciary duty and intentional interference with the contract. The Company discontinued its Ridefilm business through a sale of the Ridefilm business and its assets to a third party in March 2001. Robots sought an award of over $5.0 million in damages including contingent compensation that it claims was owed under two production agreements, damages for tort claims, and punitive damages. The arbitration hearings of this matter occurred in June and October 2009. The arbitrator issued a final award on March 16, 2011, awarding Robots $0.4 million in damages and $0.3 million in pre-judgment interest to date on its claim for breach of one of the Ridefilm production agreements. The arbitrator found in the Company's favor on Robots' tort claims, and awarded Robots no damages on its claim for breach of the second production agreement. Despite finding in the Company's favor on the vast majority of Robots' claims, the arbitrator awarded Robots $1.2 million in attorneys' fees and costs pursuant to the attorneys' fee provision set forth in the production agreements. Robots initiated two separate proceedings in California and in Ontario, Canada, to confirm the award. On July 13, 2011, a California district court granted Robots' petition to confirm the award, and denied the Company's petition to vacate the award. On August 18, 2011, the Company appealed the district court's denial of its petition to vacate to the United States Court of Appeals for the Ninth Circuit. On January 12, 2012, the Company, Ridefilm and Robots entered into a confidential settlement agreement, pursuant to which the parties fully and finally resolved and settled all claims between them relating to this dispute. The Company dismissed the Ninth Circuit appeal on January 27, 2012, and the parties filed their respective Notices of Abandonment of the Ontario proceedings with the court of February 17, 2012, resulting in a dismissal of those proceedings.

(d) The Company and certain of its officers and directors were named as defendants in eight purported class action lawsuits filed between August 11, 2006 and September 18, 2006, alleging violations of U.S. federal securities laws. These eight actions were filed in the U.S. District Court for the Southern District of New York. On January 18, 2007, the Court consolidated all eight class action lawsuits and appointed Westchester Capital Management, Inc. as the lead plaintiff and Abbey Spanier Rodd & Abrams, LLP as lead plaintiff's counsel. On October 2, 2007, plaintiffs filed a consolidated amended class action complaint. The amended complaint, brought on behalf of shareholders who purchased the Company's common stock on the NASDAQ between February 27, 2003 and July 20, 2007 (the “U.S. Class”), alleges primarily that the defendants engaged in securities fraud by disseminating materially false and misleading statements during the class period regarding the Company's revenue recognition of theater system installations, and failing to disclose material information concerning the Company's revenue recognition practices. The amended complaint also added PricewaterhouseCoopers LLP, the Company's auditors, as a defendant. On April 14, 2011, the Court issued an order appointing The Merger Fund as the lead plantiff and Abbey Spanier Rodd & Abrams, LLP as lead plantiff's counsel. On November 2, 2011, the parties entered into a memorandum of understanding containing the terms and conditions of a settlement of this action. On January 26, 2012, the parties executed and filed with the Court a formal stipulation of settlement and proposed form of notice to the class, which the Court preliminarily approved on February 1, 2012. Under the terms of the settlement, members of the U.S. Class who did not opt out of the settlement will release defendants from liability for all claims that were alleged in this action or could have been alleged in this action or any other proceeding (including the action in Canada as described in (e) of this note (the “Canadian Action”)) relating to the purchase of IMAX securities on the NASDAQ from February 27, 2003 and July 20, 2007 or the subject matter and facts relating to this action. As part of the settlement and in exchange for the release, defendants will pay $12.0 million to a settlement fund which amount will be funded by the carriers of the Company's directors and officers insurance policy and by PricewaterhouseCoopers LLP. On March 26, 2012, the parties executed and filed with the Court an amended formal stipulation of settlement and proposed form of notice to the class, which the court preliminarily approved on March 28, 2012. On June 20, 2012, the court issued an order granting final approval of the settlement. The settlement is conditioned on the Company's receipt of an order from the court in the Canadian Action excluding from the class in the Canadian Action every member of the class in both actions who has not opted out of the U.S. settlement. The hearing on the motion for the order from the court in the Canadian Action occurred on July 30, 2012 and a decision from the court is pending.

(e) A class action lawsuit was filed on September 20, 2006 in the Ontario Superior Court of Justice against the Company and certain of its officers and directors, alleging violations of Canadian securities laws. This lawsuit was brought on behalf of shareholders who acquired the Company's securities between February 17, 2006 and August 9, 2006. The lawsuit seeks $210.0 million in compensatory and punitive damages, as well as costs. For reasons released December 14, 2009, the Court granted leave to the Plaintiffs to amend their statement of claim to plead certain claims pursuant to the Securities Act (Ontario) against the Company and certain individuals and granted certification of the action as a class proceeding. These are procedural decisions, and do not contain any conclusions binding on a judge at trial as to the factual or legal merits of the claim. Leave to appeal those decisions was denied. The Company believes the allegations made against it in the statement of claim are meritless and will vigorously defend the matter, although no assurance can be given with respect to the ultimate outcome of such proceedings. The Company's directors and officers insurance policy provides for reimbursement of costs and expenses incurred in connection with this lawsuit as well as potential damages awarded, if any, subject to certain policy limits, exclusions and deductibles.

(f) In addition to the matters described above, the Company is currently involved in other legal proceedings which, in the opinion of the Company's management, will not materially affect the Company's financial position or future operating results, although no assurance can be given with respect to the ultimate outcome of any such proceedings.

(g) In the normal course of business, the Company enters into agreements that may contain features that meet the definition of a guarantee. The Guarantees Topic of the FASB ASC defines a guarantee to be a contract (including an indemnity) that contingently requires the Company to make payments (either in cash, financial instruments, other assets, shares of its stock or provision of services) to a third party based on (a) changes in an underlying interest rate, foreign exchange rate, equity or commodity instrument, index or other variable, that is related to an asset, a liability or an equity security of the counterparty, (b) failure of another party to perform under an obligating agreement or (c) failure of another third party to pay its indebtedness when due.

Financial Guarantees

The Company has provided no significant financial guarantees to third parties.

Product Warranties

The following summarizes the accrual for product warranties that was recorded as part of accrued liabilities in the condensed consolidated balance sheets:

	September 30,		December 31,
	2012		2011
Balance at the beginning of period	$	94	$	160
Warranty redemptions		(66)		(152)
Warranties issued		28		146
Revisions		(48)		(60)
Balance at the end of period	$	8	$	94

Director/Officer Indemnifications

The Company's General By-law contains an indemnification of its directors/officers, former directors/officers and persons who have acted at its request to be a director/officer of an entity in which the Company is a shareholder or creditor, to indemnify them, to the extent permitted by the Canada Business Corporations Act, against expenses (including legal fees), judgments, fines and any amount actually and reasonably incurred by them in connection with any action, suit or proceeding in which the directors and/or officers are sued as a result of their service, if they acted honestly and in good faith with a view to the best interests of the Company. The nature of the indemnification prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. The Company has purchased directors' and officers' liability insurance. No amount has been accrued in the condensed consolidated balance sheets as at September 30, 2012 and December 31, 2011 with respect to this indemnity.

Other Indemnification Agreements

In the normal course of the Company's operations, the Company provides indemnifications to counterparties in transactions such as: theater system lease and sale agreements and the supervision of installation or servicing of the theater systems; film production, exhibition and distribution agreements; real property lease agreements; and employment agreements. These indemnification agreements require the Company to compensate the counterparties for costs incurred as a result of litigation claims that may be suffered by the counterparty as a consequence of the transaction or the Company's breach or non-performance under these agreements. While the terms of these indemnification agreements vary based upon the contract, they normally extend for the life of the agreements. A small number of agreements do not provide for any limit on the maximum potential amount of indemnification; however, virtually all of the Company's system lease and sale agreements limit such maximum potential liability to the purchase price of the system. The fact that the maximum potential amount of indemnification required by the Company is not specified in some cases prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. Historically, the Company has not made any significant payments under such indemnifications and no amounts have been accrued in the condensed consolidated financial statements with respect to the contingent aspect of these indemnities.

Condensed Consolidated Statements of Operations Supplemental Information

9 Months Ended

Sep. 30, 2012

Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]

Condensed Consolidated Statements of Operations Supplemental Information

(a) Selling Expenses

The Company defers direct selling costs such as sales commissions and other amounts related to its sale and sales-type lease arrangements until the related revenue is recognized. These costs, included in costs and expenses applicable to revenues-equipment and product sales, totaled $0.9 million and $2.1 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.6 million and $1.4 million, respectively).

Film exploitation costs, including advertising and marketing, totaled $0.5 million and $3.4 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.8 million and $3.6 million, respectively) and are recorded in costs and expenses applicable to revenues-services as incurred.

Commissions are recognized as costs and expenses applicable to revenues-rentals in the month they are earned. These costs totaled $0.5 million and $1.0 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.5 million and $1.4 million, respectively). Direct advertising and marketing costs for each theater are charged to costs and expenses applicable to revenues-rentals as incurred. These costs totaled $0.6 million and $1.1 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.8 million and $2.1 million, respectively).

(b) Foreign Exchange

Included in selling, general and administrative expenses for the three and nine months ended September 30, 2012 is a gain of $0.3 million and a gain of $1.2 million, respectively, for net foreign exchange gains/losses related to the translation of foreign currency denominated monetary assets and liabilities and unhedged foreign exchange contracts compared with a loss of $4.1 million and loss of $3.5 million for the three and nine months ended September 30, 2011, respectively. See note 17(d) for additional information.

Joint Revenue Sharing Arrangements

In a joint revenue sharing arrangement, the Company receives a portion of a theater's box-office and concession revenues and in some cases a small upfront or initial payment, in exchange for placing a theater system at the theater operator's venue. Under joint revenue sharing arrangements, the customer has the ability and the right to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company's joint revenue sharing arrangements are typically non-cancellable for 7 to 10 years with renewal provisions. Title to equipment under joint revenue sharing arrangements does not transfer to the customer. The Company's joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement's shipping terms and ending on the date the theater systems are delivered back to the Company.

The Company has signed joint revenue sharing agreements with 28 exhibitors for a total of 436 theater systems, of which 287 theaters were operating as of September 30, 2012, the terms of which are similar in nature, rights and obligations. The accounting policy for the Company's joint revenue sharing arrangements is disclosed in note 2(n) of the Company's 2011 Form 10-K.

Amounts attributable to transactions arising between the Company and its customers under joint revenue sharing arrangements are included in Rentals revenue and for the three and nine months ended September 30, 2012 amounted to $13.2 million and $40.5 million, respectively (2011 — $10.0 million and $22.4 million, respectively).

IMAX DMR

In an IMAX DMR arrangement, the Company transforms conventional motion pictures into the Company's large screen format, allowing the release of Hollywood content to the IMAX theater network. In a typical IMAX DMR film arrangement, the Company will absorb its costs for the digital re-mastering of the film and then recoup this cost from a percentage of the gross box-office receipts of the film, which generally range from 10-15%. The Company does not typically hold distribution rights or the copyright to these films.

For the nine months ended September 30, 2012, the majority of IMAX DMR revenue was earned from the exhibition of 26 IMAX DMR films through the IMAX theater network. The Company has entered into arrangements with film producers to convert 9 additional films which are expected to be released during the remainder of 2012, the terms of which are similar in nature, rights and obligations. The accounting policy for the Company's IMAX DMR arrangements is disclosed in note 2(n) of the Company's 2011 Form 10-K.

Amounts attributable to transactions arising between the Company and its customers under IMAX DMR arrangements are included in Services revenue and for the three and nine months ended September 30, 2012 amounted to $25.3 million and $58.8 million, respectively (2011 — $18.6 million and $38.3 million, respectively).

Co-Produced Film Arrangements

In certain film arrangements, the Company co-produces a film with a third party whereby the third party retains the copyright and rights to the film, except that the Company obtains exclusive theatrical distribution rights to the film. Under these arrangements, both parties contribute funding to the Company's wholly-owned production company for the production of the film and for associated exploitation costs. Clauses in the film arrangements generally provide for the third party to take over the production of the film if the cost of the production exceeds its approved budget or if it appears as though the film will not be delivered on a timely basis.

The accounting policies relating to co-produced film arrangements are disclosed in notes 2(a) and 2(n) of the Company's 2011 Form 10-K.

At September 30, 2012, the Company has 4 significant co-produced film arrangements which makes up greater than 50% of the VIE total assets and liabilities balance of $14.8 million and 2 other co-produced film arrangements, the terms of which are similar.

For the three and nine months ended September 30, 2012, amounts totaling $1.5 million and $4.7 million, respectively (2011 — $2.5 million and $6.1 million, respectively) attributable to transactions between the Company and other parties involved in the production of the films have been included in cost and expenses applicable to revenues-services.

Condensed Consolidated Statements of Cash Flows Supplemental Information

9 Months Ended

Sep. 30, 2012

Condensed Consolidated Statements of Cash Flows Supplemental Information [Abstract]

Condensed Consolidated Statements of Cash Flows Supplemental Information

11. Condensed Consolidated Statements of Cash Flows Supplemental Information

(a) Changes in other non-cash operating assets and liabilities are comprised of the following:

		Nine Months
		Ended September 30,
		2012		2011
Decrease (increase) in:
	Accounts receivable	$	9,915	$	(1,224)
	Financing receivables		(4,900)		(8,471)
	Inventories		(4,169)		(5,274)
	Prepaid expenses		(955)		(1,548)
	Commissions and other deferred selling expenses		113		(44)
	Insurance recoveries		138		1,202
	Other assets		(1,313)		(1,659)
Increase (decrease) in:
	Accounts payable		(11,174)		(6,376)
	Accrued and other liabilities⁽¹⁾		(1,528)		(31,027)
	Deferred revenue		5,201		6,229
		$	(8,672)	$	(48,192)

__________

(1) Decrease in accrued and other liabilities for the nine months ended September 30, 2012 includes payments of $0.3 million for variable stock-based compensation (2011 - $23.7 million).

	(b) Cash payments made on account of:
		Nine Months
		Ended September 30,
		2012		2011
Income taxes		$	977	$	2,201
Interest		$	1,181	$	878

	(c) Depreciation and amortization are comprised of the following:
		Nine Months
		Ended September 30,
			2012		2011
Film assets		$	12,131	$	9,373
Property, plant and equipment
	Joint revenue sharing arrangements		7,384		4,914
	Other property, plant and equipment		3,186		2,866
Other intangible assets			1,507		341
Other assets			368		181
Deferred financing costs			128		345
		$	24,704	$	18,020

	(d) Write-downs, net of recoveries, are comprised of the following:
		Nine Months
		Ended September 30,
			2012		2011

Accounts receivables		$	674	$	433
Financing receivables			155		334
Inventories⁽¹⁾			503		-
Impairment of available-for-sale investment			150		-
Property, plant and equipment			18		74
Other intangible assets			11		-
Other assets			5		-
		$	1,516	$	841

__________

(1) In the nine months ended September 30, 2012, the Company recorded a charge of $0.2 million (2011 — $nil) in costs and expenses applicable to revenues – services for certain service parts inventories and a charge of $0.3 million (2011 — $nil) in costs and expenses applicable to revenues – equipment and product sales for the write-down of certain film-based inventories.

Receivable Provisions Net of Recoveries

9 Months Ended

Sep. 30, 2012

Receivable Provisions, Net of Recoveries [Abstract]

Receivable Provisions, Net of Recoveries

12. Receivable Provisions, Net of Recoveries

The following table reflects the Company's receivable provisions net of recoveries recorded in the condensed consolidated statements of operations:

	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2012		2011		2012		2011
Accounts receivable provisions, net of recoveries	$	241	$	163	$	674	$	433
Financing receivables, net of recoveries		-		245		155		334
Receivable provisions, net of recoveries	$	241	$	408	$	829	$	767

Income Taxes

9 Months Ended

Sep. 30, 2012

Income Taxes [Abstract]

Income Taxes

13. Income Taxes

(a) Income Taxes

The Company's effective tax rate differs from the statutory tax rate and varies from year to year primarily as a result of numerous permanent differences, investment and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted statutory tax rate increases or reductions in the year, changes due to foreign exchange, changes in the Company's valuation allowance based on the Company's recoverability assessments of deferred tax assets, and favorable or unfavorable resolution of various tax examinations. During the nine months ended September 30, 2012, there was no change in the Company's estimates of the recoverability of its deferred tax assets based on an analysis of both positive and negative evidence including projected future earnings.

As at September 30, 2012, the Company had net deferred income tax assets after valuation allowance of $40.2 million (December 31, 2011 — $50.0 million). As at September 30, 2012, the Company had a gross deferred income tax asset before valuation allowance of $46.3 million (December 31, 2011 — $56.1 million), against which the Company is carrying a $6.1 million valuation allowance (December 31, 2011 — $6.1 million).

Due to a change in enacted tax rates, the Company recorded an increase to deferred tax assets and a decrease to the deferred tax provision of $0.7 million in 2012.

As at September 30, 2012 and December 31, 2011, the Company had total unrecognized tax benefits (including interest and penalties) of $4.8 million and $4.4 million, respectively, for international withholding taxes. All of the unrecognized tax benefits could impact the Company's effective tax rate if recognized. While the Company believes it has adequately provided for all tax positions, amounts asserted by taxing authorities could differ from the Company's accrued position. Accordingly, additional provisions on federal, state, provincial and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.

Consistent with its historical financial reporting, the Company has elected to classify interest and penalties related to income tax liabilities, when applicable, as part of the interest expense in its condensed consolidated statement of operations rather than income tax expense. The Company recognized approximately $0.1 million and $0.2 million in potential interest and penalties associated with unrecognized tax benefits for the three and nine months ended September 30, 2012, respectively (2011 — less than $0.1 million and $0.2 million, respectively).

(b) Income Tax Effect on Comprehensive Income

The income tax (expense) benefit related to the following items included in other comprehensive income are as follows:

	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2012		2011		2012		2011

Amortization of actuarial loss on defined benefit plan	$	(23)	$	(13)	$	(69)	$	(40)
Change in market value of available-for-sale investment		-		-		(42)		61
Other-than-temporary impairment of available-for-sale investment		-		-		(19)		-
Unrealized change in cash flow hedging instruments		(153)		344		(213)		248
Realization of cash flow hedging gains upon settlement		42		21		7		219
	$	(134)	$	352	$	(336)	$	488

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

+ Details

Capital Stock

9 Months Ended

Sep. 30, 2012

Capital Stock [Abstract]

Capital Stock

14. Capital Stock

(a) Authorized

Common Shares

The authorized capital of the Company consists of an unlimited number of common shares. The following is a summary of the rights, privileges, restrictions and conditions of the common shares.

The holders of common shares are entitled to receive dividends if, as and when declared by the directors of the Company, subject to the rights of the holders of any other class of shares of the Company entitled to receive dividends in priority to the common shares.

The holders of the common shares are entitled to one vote for each common share held at all meetings of the shareholders.

(b) Stock-Based Compensation

The Company has five stock-based compensation plans that are described below. The compensation costs recorded in the condensed consolidated statement of operations for these plans were $2.8 million and $10.3 million for the three and nine months ended September 30, 2012, respectively (2011 — expense of $0.5 million and $9.2 million, respectively).

Stock Option Plan

The Company's Stock Option Plan, which is shareholder approved, permits the grant of options to employees, directors and consultants. The Company recorded an expense of $3.2 million and $9.8 million for the three and nine months ended September 30, 2012, respectively (2011 — $2.4 million and $7.2 million, respectively), related to grants issued to employees and directors in the plan. No income tax benefit is recorded in the condensed consolidated statements of operations for these costs.

The Company's policy is to issue new shares from treasury to satisfy stock options which are exercised.

The Company utilizes a lattice-binomial option-pricing model (“Binomial Model”) to determine the fair value of stock-based payment awards. The fair value determined by the Binomial Model is affected by the Company's stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company's expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The Binomial Model also considers the expected exercise multiple which is the multiple of exercise price to grant price at which exercises are expected to occur on average. Option-pricing models were developed for use in estimating the value of traded options that have no vesting or hedging restrictions and are fully transferable. Because the Company's employee stock options have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, in management's opinion, the Binomial Model best provides a fair measure of the fair value of the Company's employee stock options.

The weighted average fair value of all common share options, granted to employees for the three and nine months ended September 30, 2012 at the measurement date was $6.93 per share and $7.49 per share, respectively (2011 — $9.04 per share and $9.59 per share, respectively). The following assumptions were used:

	Three Months Ended September 30,		Nine Months Ended September 30,
	2012	2011	2012	2011

Average risk-free interest rate	1.07%	2.35%	1.38%	2.79%
Expected option life (in years)	5.29 - 5.30	5.12 - 5.15	2.89 - 5.36	1.78 - 5.15
Expected volatility	50%	50%	50%	50%
Annual termination probability	8.52% - 8.76%	8.31%	0% - 8.76%	0% - 8.49%
Dividend yield	0%	0%	0%	0%

As at September 30, 2012, the Company has reserved a total of 13,195,464 (December 31, 2011 — 13,010,548) common shares for future issuance under the Stock Option Plan, of which options in respect of 7,803,926 common shares are outstanding at September 30, 2012. All awards of stock options are made at fair market value of the Company's common shares on the date of grant. The fair market value of a common share on a given date means the higher of the closing price of a common share on the grant date (or the most recent trading date if the grant date is not a trading date) on the New York Stock Exchange (“NYSE”), the Toronto Stock Exchange (the “TSX”) and such national exchange, as may be designated by the Company's Board of Directors (the “Fair Market Value”). The options generally vest between one and 5 years and expire 10 years or less from the date granted. The Stock Option Plan provides that vesting will be accelerated if there is a change of control, as defined in the plan and upon certain conditions. At September 30, 2012, options in respect of 3,706,631 common shares were vested and exercisable.

The following table summarizes certain information in respect of option activity under the Stock Option Plan for the nine month periods ended September 30:

				Weighted Average Exercise
	Number of Shares			Price Per Share
	2012	2011	2012		2011

Options outstanding, beginning of year	7,200,721	6,743,272	$	14.60	$	10.79
Granted	1,686,862	1,122,342		24.78		31.79
Exercised	(924,579)	(528,485)		6.31		10.66
Forfeited	(154,958)	(141,600)		23.03		19.68
Expired	-	-		-		-
Cancelled	(4,120)	-		33.73		-
Options outstanding, end of period	7,803,926	7,195,529		17.61		13.90
Options exercisable, end of period	3,706,631	3,607,049		13.80		9.19

The Company cancelled 3,820 and 4,120 stock options from its Stock Option Plan (2011 — nil and nil, respectively) surrendered by Company employees during the three and nine months ended September 30, 2012, respectively.

As at September 30, 2012, 7,000,018 options were fully vested or are expected to vest with a weighted average exercise price of $16.98, aggregate intrinsic value of $41.8 million and weighted average remaining contractual life of 5.0 years. As at September 30, 2012, options that are exercisable have an intrinsic value of $31.7 million and a weighted average remaining contractual life of 4.5 years. The intrinsic value of options exercised in the three and nine months ended September 30, 2012 was $1.0 million and $15.3 million, respectively (2011 — $2.4 million and $11.2 million, respectively).

Options to Non-Employees

During the three and nine months ended September 30, 2012, an aggregate of nil and 12,500, respectively (2011 — nil and 103,944, respectively), common share options to purchase the Company's common stock with an average exercise price of n/a and $22.82, respectively (2011 — n/a and $27.64, respectively) were granted to certain advisors and strategic partners of the Company. These options granted have a maximum contractual life of 7 years and vest between one and 5 years. These options were granted under the Stock Option Plan.

As at September 30, 2012, non-employee options outstanding amounted to 120,001 options (2011 — 142,251) with a weighted average exercise price of $14.14 (2011 — $12.93). Included within the non-employee outstanding options are 15,000 options which were modified in 2011 from service based employee awards to performance based non-employee awards. 34,717 options (2011 — 49,750) were exercisable with an average weighted exercise price of $11.59 (2011 — $11.51) and the vested options have an aggregate intrinsic value of $0.3 million (2011 — $0.2 million). The weighted average fair value of options granted to non-employees during the three and nine months ended September 30, 2012 at the measurement date was n/a and $11.73 per share, respectively (2011 — n/a and $13.75 per share, respectively), utilizing a Binomial Model with the following underlying assumptions for periods ended September 30:

	Three Months		Nine Months
	Ended September 30,		Ended September 30,
	2012	2011	2012	2011

Average risk-free interest rate	n/a	n/a	1.28%	2.38%
Contractual option life	n/a	n/a	7 Years	6 years
Average expected volatility	n/a	n/a	50%	50%
Dividend yield	n/a	n/a	0%	0%

For the three and nine months ended September 30, 2012, the Company recorded a charge of less than $0.1 million and $0.1 million, respectively (2011 — $0.1 million and $0.8 million, respectively) to cost and expenses related to revenues − services and selling, general and administrative expenses related to the non-employee stock options. Included in accrued liabilities is an accrual of less than $0.1 million for non-employee stock options recorded (December 31, 2011 − $0.1 million).

Restricted Common Shares

There were no restricted common shares issued during the three and nine months ended or outstanding as at September 30, 2012 and 2011.

Stock Appreciation Rights

There has been no stock appreciation rights (“SARs”) granted since 2007. During 2007, 2,280,000 SARs with a weighted average exercise price of $6.20 per right were granted in-lieu of stock options to certain Company executives. For the three and nine months ended September 30, 2012, nil and 15,000 SARs were cash settled for $nil and $0.3 million, respectively (2011 − nil and 999,500 SARs were cash settled for $nil and $23.7 million, respectively). The average exercise price for the settled SARs for the three and nine months ended September 30, 2012 was $nil and $ 6.86, respectively (2011 − $nil and $ 6.86, respectively) per SAR. As at September 30, 2012, 118,000 SARs were outstanding, of which 100,000 SARs were exercisable. None of the SARs were forfeited, cancelled, or expired for the three and nine months ended September 30, 2012 and 2011. The SARs vesting period ranges from immediately upon granting to 5 years, with a remaining contractual life of 5.25 years as at September 30, 2012. The outstanding SARs had a weighted average fair value of $13.82 per right as at September 30, 2012 (December 31, 2011 — $12.43). The Company accounts for the obligation of these SARs as a liability (September 30, 2012 — $1.6 million; December 31, 2011 — $1.6 million), which is classified within accrued liabilities. The Company has recorded a recovery of $0.4 million and an expense of $0.3 million for the three and nine months ended September 30, 2012, respectively (2011 — recovery of $2.0 million and an expense of $1.2 million, respectively) to selling, general and administrative expenses related to these SARs. The following assumptions were used for measuring the fair value of the SARs:

	As at September 30, 2012	As at December 31, 2011

Average risk-free interest rate	0.62%	1.09%
Expected option life (in years)	2.69 - 2.77	3.18 - 3.46
Expected volatility	50%	50%
Annual termination probability	8.76%	8.76%
Dividend yield	0%	0%

Warrants

There were no warrants issued during the three and nine months ended or outstanding as at September 30, 2012 and 2011.

Reconciliations of the numerator and denominator of the basic and diluted per-share computations are comprised of the following:

	Three Months					Nine Months
	Ended September 30,					Ended September 30,
	2012		2011		2012		2011

Net income from operations applicable to common shareholders	$	14,990	$	8,392	$	28,658	$	9,214
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period		65,893		64,568		65,053		64,146
Weighted average number of shares issued during the period		37		86		665		260
Weighted average number of shares used in computing basic income per share		65,930		64,654		65,718		64,406
Assumed exercise of stock options, net of shares assumed		2,371		3,102		2,469		3,704
Weighted average number of shares used in computing diluted income per share		68,301		67,756		68,187		68,110

(d) Shareholders' Equity

The following summarizes the movement of Shareholders' Equity for the nine months ended September 30, 2012:

Balance as at December 31, 2011		$	192,907
Issuance of common shares for stock options exercised			5,831
Net income			28,658
Adjustments to other equity:
	Employee stock options granted		9,841
	Non-employee stock options granted		115
	Stock options exercised		(879)
Adjustment to capital stock for stock options exercised			879
Adjustments to accumulated other comprehensive loss:
	Unrealized net gain from cash flow hedging instruments		826
	Realization of cash flow hedging net gain upon settlement		(22)
	Amortization of actuarial loss on defined benefit plan		273
	Change in market value of available-for-sale investment		338
	Other-than-temporary impairment of available-for-sale investment		150
	Tax effect of movement in accumulated other comprehensive income		(336)
Balance as at September 30, 2012		$	238,581

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section B
-Paragraph 7, 11A
-Chapter 1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Segmented Information

9 Months Ended

Sep. 30, 2012

Segmented Information [Abstract]

Segmented Information

15. Segmented Information

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment. The theater system maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment provides IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment produces films and performs film re-mastering services. The film distribution segment distributes films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The Company refers to all theaters using the IMAX theater system as “IMAX theaters.” The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items. The accounting policies of the segments are the same as those described in note 2 to the audited consolidated financial statements included in the Company's 2011 Form 10-K.

The Company's Chief Operating Decision Maker (“CODM”), as defined in the Segment Reporting Topic of the FASB ASC, assesses segment performance based on segment revenues, gross margins and film performance. Selling, general and administrative expenses, research and development costs, amortization of intangibles, receivables provisions (recoveries), write-downs net of recoveries, interest income, interest expense and tax (provision) recovery are not allocated to the segments.

Transactions between the film production and IMAX DMR segment and the film post-production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

Transactions between the other segments are not significant.

		Three Months				Nine Months
		Ended September 30,				Ended September 30,
			2012		2011	2012		2011
Revenue⁽¹⁾
IMAX systems		$	25,358	$	20,649	$	59,063	$	63,378
Theater system maintenance			7,042		6,348		20,878		18,270
Joint revenue sharing arrangements			13,186		9,995		40,477		22,382
Films
	Production and IMAX DMR		25,223		18,600		58,805		38,280
	Distribution		3,259		4,965		11,122		12,857
	Post-production		1,646		3,023		5,778		5,686
Other			4,997		3,908		10,394		9,027
Total		$	80,711	$	67,488	$	206,517	$	169,880

Gross margins
IMAX systems⁽²⁾		$	15,956	$	13,294	$	34,475	$	36,469
Theater system maintenance			2,828		1,944		8,122		6,912
Joint revenue sharing arrangements⁽²⁾			9,286		6,733		28,340		13,792
Films
	Production and IMAX DMR⁽²⁾		15,426		12,015		35,714		21,235
	Distribution⁽²⁾		587		1,418		2,133		2,531
	Post-production		103		808		1,373		2,804
Other			564		226		287		(357)
Total		$	44,750	$	36,438	$	110,444	$	83,386

_________

(1) For the three and nine months ended September 30, 2012, the Company's two largest customers collectively represent 15.0% and 16.5%, respectively, of total revenues (2011 — 17.3% and 17.8%, respectively). In the third quarter of 2012, Dalian Wanda Group Co., Ltd., the parent company of Wanda Cinema Line Corporation (“Wanda”), acquired AMC Entertainment Holdings, Inc. (“AMC”). Prior to this transaction, AMC and Wanda were the Company's first and third largest customers. Under common ownership the Wanda/AMC entity is the Company's largest customer. Revenues from this customer are included across all of the Company's segments. Prior year figures have been restated to reflect the change in the Company's largest customers.

(2) IMAX systems include commission costs of $0.9 million and $2.1 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.6 million and $1.4 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.1 million and $2.1 million for the three and nine months ended September 30, 2012, respectively (2011 — $1.3 million and $3.6 million, respectively). Production and DMR segment margins include marketing costs of $0.5 million and $2.2 million for the three and nine months ended September 30, 2012, respectively (2011 — $0.7 million and $1.9 million, respectively). Distribution segment margins include a marketing cost recovery of less than $0.1 million and an expense of $1.2 million for the three and nine months ended September 30, 2012, respectively (2011 — expense of $0.1 million and $1.7 million, respectively).

		September 30,		December 31,
			2012		2011
Assets
IMAX systems		$	155,107	$	154,312
Theater system maintenance			13,376		13,008
Joint revenue sharing arrangements			123,404		120,483
Films
	Production and IMAX DMR		10,628		16,577
	Distribution		6,737		4,504
	Post-production		4,064		4,185
Other			3,095		2,718
Corporate and other non-segment specific assets			110,624		90,449
Total		$	427,035	$	406,236

Geographic Information

Revenue by geographic area is based on the location of the customer. Revenue related to IMAX DMR is presented based upon the geographic location of the theaters that exhibit the re-mastered films. IMAX DMR revenue is generated through contractual relationships with studios and other third parties and these may not be in the same geographical location as the theater. Comparative numbers related to IMAX DMR revenue have been adjusted to conform to the current period presentation.


	Three Months				Nine Months
	Ended September 30,				Ended September 30,
		2012		2011		2012		2011
Revenue
United States	$	38,897	$	30,030	$	98,007	$	82,713
Asia (excluding Greater China)		8,822		6,252		18,687		13,735
Russia and the CIS		7,994		2,804		14,615		13,620
Greater China		7,567		7,949		29,002		17,893
Canada		6,357		6,846		14,289		13,314
Rest of the World		5,212		6,281		13,778		9,074
Western Europe		4,426		6,078		15,201		14,758
Rest of Europe		775		626		1,396		3,334
Mexico		661		622		1,542		1,439
Total	$	80,711	$	67,488	$	206,517	$	169,880

No single country in the Rest of the World, Western Europe, Rest of Europe or Asia (excluding Greater China) classifications comprise more than 5% of the total revenue.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 131
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Employees Pension and Postretirement Benefits

9 Months Ended

Sep. 30, 2012

Employees Pension and Postretirement Benefits [Abstract]

Employees Pension and Postretirement Benefits

16. Employee's Pension and Postretirement Benefits

(a) Defined Benefit Plan

The Company has an unfunded U.S. defined benefit pension plan (the “SERP”) covering Richard L. Gelfond, Chief Executive Officer (“CEO”) of the Company and Bradley J. Wechsler, Chairman of the Company's Board of Directors. The SERP provides for a lifetime retirement benefit from age 55 determined as 75% of the member's best average 60 consecutive months of earnings over the member's employment history. The benefits were 50% vested as at July 2000, the SERP initiation date. The vesting percentage increases on a straight-line basis from inception until age 55. As at September 30, 2012, the benefits of Mr. Gelfond were 100% vested. Upon a termination for cause, prior to a change of control, the executive shall forfeit any and all benefits to which such executive may have been entitled, whether or not vested.

Under the terms of the SERP, if Mr. Gelfond's employment terminated other than for cause, he is entitled to receive SERP benefits in the form of a lump sum payment. SERP benefit payments to Mr. Gelfond are subject to a deferral for six months after the termination of his employment, at which time Mr. Gelfond will be entitled to receive interest on the deferred amount credited at the applicable federal rate for short-term obligations. The term of Mr. Gelfond's current employment agreement has been extended through December 31, 2013. Under the terms of the extension, Mr. Gelfond also agreed that any compensation earned during 2011, 2012 and 2013 would not be included in calculating his entitlement under the SERP.

The amounts accrued for the SERP are determined as follows:

	September 30,		December 31,
	2012		2011

Obligation, beginning of period	$	18,990	$	18,108
Interest cost		204		279
Actuarial loss		-		603
Obligation, end of period and unfunded status	$	19,194	$	18,990

On August 1, 2010, the Company made a lump sum payment to Mr. Wechsler in accordance with the terms of the plan, representing a settlement in full of Mr. Wechsler's entitlement under the SERP.

	The following table provides disclosure of pension expense for the SERP:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2011		2012		2011
Interest cost		$	68	$	69	$	204	$	209
Amortization of actuarial loss			91		53		273		161
Pension expense		$	159	$	122	$	477	$	370

The accumulated benefit obligation for the SERP was $19.2 million at September 30, 2012 (December 31, 2011 - $19.0 million).

The following amounts were included in accumulated other comprehensive income (“AOCI”) and will be recognized as components of net periodic benefit cost in future periods:

	As at		As at
	September 30,		December 31,
	2012		2011

Unrecognized actuarial loss	$	2,355	$	2,628

No contributions are expected to be made for the SERP during 2012. The Company expects interest costs of $0.1 million and amortization of actuarial losses of $0.1 million to be recognized as a component of net periodic benefit cost during the remainder of 2012.

The following benefit payments are expected to be made as per the current SERP assumptions and the terms of the SERP in each of the next 5 years, and in the aggregate:

2012 (three months remaining)	$	-
2013		-
2014		19,676
2015		-
2016		-
Thereafter		-
	$	19,676

(b) Defined Contribution Plan

The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums. During the three and nine months ended September 30, 2012, the Company contributed and expensed an aggregate of $0.3 million and $0.8 million, respectively (2011 — $0.2 million and $0.7 million, respectively), to its Canadian plan and an aggregate of less than $0.1 million and $0.2 million, respectively (2011 — less than $0.1 million and $0.1 million, respectively), to its defined contribution employee pension plan under Section 401(k) of the U.S. Internal Revenue Code.

The Company has an unfunded postretirement plan for Messrs. Gelfond and Wechsler. The plan provides that the Company will maintain health benefits for Messrs. Gelfond and Wechsler until they become eligible for Medicare and, thereafter, the Company will provide Medicare supplement coverage as selected by Messrs. Gelfond and Wechsler. The postretirement benefits obligation as at September 30, 2012 is $0.6 million (December 31, 2011 — $0.5 million). The Company has expensed less than $0.1 million and $0.1 million for the three and nine months ended September 30, 2012, respectively (2011 — less than $0.1 million and less than $0.1 million, respectively).

The following benefit payments are expected to be made as per the current plan assumptions in each of the next 5 years:

2012 (three months remaining)	$	15
2013		16
2014		35
2015		38
2016		42
Thereafter		407
	$	553

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI http://asc.fasb.org/topic&trid=2235017

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Implementation Guide (Q and A)
-Number FAS88
-Paragraph 63
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 106
-Paragraph 518
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 03-2
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 87
-Paragraph 264
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph q
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 8
-Subparagraph m
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 158
-Paragraph 7, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS106-2
-Paragraph 20, 21, 22
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 30
-Paragraph 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Financial Instruments

9 Months Ended

Sep. 30, 2012

Financial Instruments [Abstract]

Financial Instruments

17. Financial Instruments

(a) Financial Instruments

The Company maintains cash with various major financial institutions. The Company's cash is invested with highly rated financial institutions.

The Company's accounts receivables and financing receivables are subject to credit risk. The Company's accounts receivable and financing receivables are concentrated with the theater exhibition industry and film entertainment industry. To minimize the Company's credit risk, the Company retains title to underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. The Company believes it has adequately provided for related exposures surrounding receivables and contractual commitments.

(b) Fair Value Measurements

The carrying values of the Company's cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities due within one year approximate fair values due to the short-term maturity of these instruments. The Company's other financial instruments are comprised of the following:

		As at September 30, 2012				As at December 31, 2011
		Carrying		Estimated		Carrying		Estimated
		Amount		Fair Value		Amount		Fair Value
Borrowings under Credit Facility	$	(30,000)	$	(30,000)	$	(55,083)	$	(55,083)
Net financed sales receivable	$	78,211	$	75,925	$	67,300	$	65,846
Net investment in sales-type leases	$	13,322	$	13,730	$	19,414	$	20,448
Available-for-sale investment	$	1,350	$	1,350	$	1,012	$	1,012
Foreign exchange contracts — designated forwards	$	621	$	621	$	(182)	$	(182)
Foreign exchange contracts — non-designated forwards	$	345	$	345	$	(645)	$	(645)

The carrying value of borrowings under the Credit Facility approximates fair value as the interest rates offered under the Credit Facility are close to September 30, 2012 and December 31, 2011 market rates for the Company for debt of the same remaining maturities (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2012 and December 31, 2011, respectively.

The estimated fair values of the net financed sales receivable and net investment in sales-type leases are estimated based on discounting future cash flows at currently available interest rates with comparable terms (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2012 and December 31, 2011, respectively.

The fair value of the Company's available-for-sale investment is determined using the present value of expected cash flows based on projected earnings and other information readily available from the business venture (Level 3 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2012 and December 31, 2011, respectively. The discounted cash flow valuation technique is based on significant unobservable inputs of revenue and expense projections, appropriately risk weighted, as the investment is in a start-up entity. The significant unobservable inputs used in the fair value measurement of the Company's available-for-sale investment are long-term revenue growth and pretax operating margin. A significant increase (decrease) in any of those inputs in isolation would result in a lower or higher fair value measurement.

The fair value of foreign currency derivatives are determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2012 and December 31, 2011, respectively. These identical instruments are traded on a closed exchange.

There were no significant transfers between Level 1 and Level 2 during the nine months ended September 30, 2012 or 2011. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. The table below sets forth a summary of changes in the fair value of the Company's available-for-sale investment measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the period:


			Available For Sale Investments
			2012		2011

Beginning balance, January 1,			$	1,012	$	1,500
	Transfers into/out of Level 3			-		-
	Total gains or losses (realized/unrealized)
		Included in earnings		-		-
		Change in other comprehensive income		338		(488)
	Purchases, issuances, sales and settlements			-		-
Ending balance, September 30,			$	1,350	$	1,012

The amount of total gains or losses for the period included in earnings attributable to the
	change in unrealized gains or losses relating to assets still held at the reporting date		$	(150)	$	-

There were no transfers in or out of the Company's level 3 assets during the nine months ended September 30, 2012.

In the nine months ended September 30, 2012, the Company recognized a $0.2 million other-than-temporary impairment of its available-for-sale investment, in “Impairment of available-for-sale investment” in the condensed consolidated statement of operations, as the value is not expected to recover based on the length of time and extent to which the market value has been less than cost.

The Company's net investment in leases and its net financed sale receivables are subject to the disclosure requirements of ASC 310 “Receivables.” Due to differing risk profiles of its net investment in leases and its net financed sales receivables, the Company views its net investment in leases and its net financed sale receivables as separate classes of financing receivables. The Company does not aggregate financing receivables to assess impairment.

The Company monitors the credit quality of each customer on a frequent basis through collections and aging analyses. The Company also holds meetings monthly in order to identify credit concerns and whether a change in credit quality classification is required for the customer. A customer may improve in their credit quality classification once a substantial payment is made on overdue balances or the customer has agreed to a payment plan with the Company and payments have commenced in accordance to the payment plan. The change in credit quality indicator is dependant upon management approval.

The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:

Good standing — Theater continues to be in good standing with the Company as the client's payments and reporting are up-to-date.

Credit Watch — Theater operator has begun to demonstrate a delay in payments, has been placed on the Company's credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance, length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "Pre-approved transactions" category, but not in as good of condition as those receivables in "Good standing."

Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "all transactions suspended" category, but not in as good of condition as those receivables in "Credit Watch." Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired.

All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended”, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped.

The following table discloses the recorded investment in financing receivables by credit quality indicator:

	As at September 30, 2012						As at December 31, 2011
	Minimum		Financed				Minimum		Financed
	Lease		Sales				Lease		Sales
	Payments		Receivables		Total		Payments		Receivables		Total

In good standing	$	11,318	$	70,027	$	81,345	$	15,667	$	55,907	$	71,574
Credit watch		187		7,272		7,459		1,506		3,718		5,224
Pre-approved transactions		783		296		1,079		1,837		7,272		9,109
Transactions suspended		2,164		682		2,846		2,237		719		2,956
	$	14,452	$	78,277	$	92,729	$	21,247	$	67,616	$	88,863

While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income. During the quarter ended September 30, 2012, a financing receivable was modified as a troubled debt restructuring. The customer has paid all overdue amounts in accordance with such restructuring which has resulted in a change in the credit quality classification from 'pre-approved transactions' to 'in good standing'.

The Company's investment in financing receivables on nonaccrual status is as follows:


	As at September 30, 2012				As at December 31, 2011
	Recorded		Related		Recorded		Related
	Investment		Allowance		Investment		Allowance

Net investment in leases	$	2,947	$	(1,130)	$	4,692	$	(1,833)
Net financed sales receivables		978		(66)		1,329		(316)
	$	3,925	$	(1,196)	$	6,021	$	(2,149)

The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater's aging exceeds 90 days, the Company's policy is to review and assess collectibility on the theater's past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.

The Company's aged financing receivables are as follows:


	As at September 30, 2012
									Related						Recorded
							Billed		Unbilled		Total				Investment
							Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	208	$	95	$	1,143	$	1,446	$	13,006	$	14,452	$	(1,130)	$	13,322
Net financed sales receivables		1,125		549		1,037		2,711		75,566		78,277		(66)		78,211
Total	$	1,333	$	644	$	2,180	$	4,157	$	88,572	$	92,729	$	(1,196)	$	91,533



	As at December 31, 2011
									Related						Recorded
							Billed		Unbilled		Total				Investment
							Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	350	$	261	$	1,754	$	2,365	$	18,882	$	21,247	$	(1,833)	$	19,414
Net financed sales receivables		723		593		1,029		2,345		65,270		67,616		(316)		67,300
Total	$	1,073	$	854	$	2,783	$	4,710	$	84,152	$	88,863	$	(2,149)	$	86,714

The Company's recorded investment in past due financing receivables for which the Company continues to accrue finance income is as follows:

	As at September 30, 2012
									Related				Recorded
							Billed		Unbilled				Investment
							Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	7	$	14	$	21	$	42	$	145	$	-	$	187
Net financed sales receivables		239		314		649		1,202		15,284		-		16,486
Total	$	246	$	328	$	670	$	1,244	$	15,429	$	-	$	16,673


	As at December 31, 2011
									Related				Recorded
							Billed		Unbilled				Investment
							Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	67	$	118	$	144	$	329	$	3,766	$	-	$	4,095
Net financed sales receivables		202		345		674		1,221		16,343		-		17,564
Total	$	269	$	463	$	818	$	1,550	$	20,109	$	-	$	21,659

The Company considers financing receivables to be impaired when it believes it to be probable that it will not recover the full amount of principal and interest owing under the arrangement. The Company uses its knowledge of the industry and economic trends, as well as its prior experiences to determine the amount recoverable for impaired financing receivables. The following table discloses information regarding the Company's impaired financing receivables:

		For the Three Months Ended September 30, 2012
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		671		195		(66)		671		-

Recorded investment for which there is no related allowance:
	Net financed sales receivables		385		19		-		474		11

Total recorded investment in impaired loans:
	Net financed sales receivables	$	1,056	$	214	$	(66)	$	1,145	$	11

		For the Three Months Ended September 30, 2011
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		225		208		(66)		227		-

Total recorded investment in impaired loans:
	Net financed sales receivables	$	225	$	208	$	(66)	$	227	$	-

		For the Nine Months Ended September 30, 2012
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		671		195		(66)		204		-

Recorded investment for which there is no related allowance:
	Net financed sales receivables		385		19		-		512		11

Total recorded investment in impaired loans:
	Net financed sales receivables	$	1,056	$	214	$	(66)	$	716	$	11

		For the Nine Months Ended September 30, 2011
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		225		208		(66)		235		-

Total recorded investment in impaired loans:
	Net financed sales receivables	$	225	$	208	$	(66)	$	235	$	-

The Company's activity in the allowance for credit losses for the period and the Company's recorded investment in financing receivables is as follows:

		Three Months Ended September 30, 2012					Nine Months Ended September 30, 2012
		Net Investment		Net Financed			Net Investment		Net Financed
		in Leases		Sales Receivables			in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance		$	1,892	$	173		$	1,833	$	316
	Charge-offs		(762)		(107)	⁽¹⁾		(1,019)		(109)	⁽¹⁾
	Provision		-		-			316		(141)
Ending balance		$	1,130	$	66		$	1,130	$	66

Ending balance: individually evaluated for impairment		$	1,130	$	66		$	1,130	$	66

Financing receivables:

Ending balance: individually evaluated for impairment		$	14,452	$	78,277		$	14,452	$	78,277


		Three Months Ended September 30, 2011					Nine Months Ended September 30, 2011
		Net Investment		Net Financed			Net Investment		Net Financed
		in Leases		Sales Receivables			in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance		$	2,592	$	66		$	4,838	$	66
	Charge-offs		(363)		-			(2,808)		-
	Provision		320		-			519		-
Ending balance		$	2,549	$	66		$	2,549	$	66

Ending balance: individually evaluated for impairment		$	2,549	$	66		$	2,549	$	66



Financing receivables:

Ending balance: individually evaluated for impairment		$	22,000	$	61,939		$	22,000	$	61,939

_________

As a result of a troubled debt restructuring in the period ended September 30, 2012, the Company recorded a $0.1 million write-down on a $0.5 million recorded investment.

(d) Foreign Exchange Risk Management

The Company is exposed to market risk from changes in foreign currency rates. A majority portion of the Company's revenues is denominated in U.S. dollars while a substantial portion of its costs and expenses is denominated in Canadian dollars. A portion of the net U.S. dollar cash flows of the Company is periodically converted to Canadian dollars to fund Canadian dollar expenses through the spot market. In Japan, the Company has ongoing operating expenses related to its operations in Japanese yen. Net Japanese yen cash flows are converted to U.S. dollars generally through the spot market. The Company also has cash receipts under leases denominated in Chinese Renminbi, Japanese yen, Canadian dollar and Euros which are converted to U.S. dollars generally through the spot market. The Company's policy is to not use any financial instruments for trading or other speculative purposes.

The Company entered into a series of foreign currency forward contracts to manage the Company's risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests at September 30, 2012 (the “Foreign Currency Hedges”), with settlement dates throughout 2013. In addition, at September 30, 2012, the Company held foreign currency forward contracts to manage foreign currency risk on future anticipated Canadian dollar expenditures that were not considered Foreign Currency Hedges by the Company. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the condensed consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the condensed consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations.

The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company's condensed consolidated financial statements:

Notional value foreign exchange contracts as at:

		September 30,		December 31,
			2012		2011
Derivatives designated as hedging instruments:
	Foreign exchange contracts - Forwards	$	13,500	$	20,581

Derivatives not designated as hedging instruments:
	Foreign exchange contracts - Forwards		7,274		67,341
		$	20,774	$	87,922

Fair value of derivatives in foreign exchange contracts as at:

			September 30,		December 31,
		Balance Sheet Location	2012		2011
Derivatives designated as hedging instruments:
	Foreign exchange contracts — Forwards	Other Assets (Accrued liabilities)	$	621	$	(182)

Derivatives not designated as hedging instruments:
	Foreign exchange contracts — Forwards	Other Assets (Accrued liabilities)		345		(645)
			$	966	$	(827)

Derivatives in Foreign Currency Hedging relationships are as follows:

		Three Months Ended September 30,				Nine Months Ended September 30,
			2012		2011		2012		2011
Foreign exchange contracts - Forwards	Derivative Gain (Loss) Recognized in OCI (Effective Portion)	$	589	$	(1,151)	$	826	$	(800)
		$	589	$	(1,151)	$	826	$	(800)

	Location of Derivative
	Gain Reclassified from
	AOCI into Income	Three Months Ended September 30,				Nine Months Ended September 30,
	(Effective Portion)		2012		2011		2012		2011
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	158	$	229	$	22	$	953
		$	158	$	229	$	22	$	953

Non Designated Derivatives in Foreign Currency relationships are as follows:

		Three Months Ended September 30,				Nine Months Ended September 30,
	Location of Derivative Gain (Loss)		2012		2011		2012		2011
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	400	$	(3,893)	$	1,229	$	(3,172)
		$	400	$	(3,893)	$	1,229	$	(3,172)

(e) Investments in New Business Ventures

The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323 and the FASB ASC 320, as appropriate. As at September 30, 2012, the equity method of accounting is being utilized for an investment with a carrying value of $3.4 million (December 31, 2011 — $4.1 million). For the three months ended September 30, 2012, gross revenues, cost of revenue and net loss for the investment were $2.7 million, $2.9 million and $3.0 million, respectively (2011 — $0.7 million, $2.7 million and $4.3 million, respectively). For the nine months ended September 30, 2012, gross revenues, cost of revenue and net loss for the investment $6.5 million, $8.9 million and $9.9 million, respectively (2011 — $1.2 million, $6.5 million and $12.9 million, respectively). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. The difference between the Company's investment balance and the amount of underlying equity in net assets owned by the Company amounts to $1.3 million and relates to goodwill. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under the FASB ASC 320 and is recorded at its fair value of $1.3 million at September 30, 2012 (December 31, 2011 — $1.0 million). In the nine months ended September 30, 2012, the Company recognized an other-than-temporary impairment for its investment of $0.2 million, respectively (2011 —$nil). This investment is classified as an available-for-sale investment. The total carrying value of investments in new business ventures at September 30, 2012 is $4.7 million (December 31, 2011 — $5.1 million) and is recorded in Other Assets.

Basis of Presentation (Policies)	9 Months Ended
Basis of Presentation (Policies)	Sep. 30, 2012
Basis of Presentation and Condensed Consolidated Statements of Operations Supplemental Information [Abstract]
Variable interest entities	The condensed consolidated financial statements include the accounts of the Company together with its wholly-owned subsidiaries, and any entities which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. The nature of the Company's business is such that the results of operations for the interim periods presented are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments necessary to make the results of operations for the interim periods a fair statement of such operations. The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”). The Company has 9 film production companies that are VIEs. For two of the Company's film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE's economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. The Company continues to consolidate these entities, with no material impact on the operating results or financial condition of the Company, as these production companies have total assets and total liabilities of $nil as at September 30, 2012 (December 31, 2011 — $nil). For the other 7 film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at September 30, 2012, these 7 VIEs have total assets and total liabilities of $14.8 million (December 31, 2011 — $12.7 million). Earnings of the investees included in the Company's condensed consolidated statement of operations amounted to $nil and $nil for the three and nine months ended September 30, 2012, respectively (2011 — $nil and $nil, respectively). The carrying value of these investments in VIEs that are not consolidated is $nil at September 30, 2012 (December 31, 2011 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the condensed consolidated statement of operations. The Company's exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $0.3 million at September 30, 2012.
ASC 323	The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) and ASC 320 − “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate. At September 30, 2012, the equity method of accounting is being utilized for an investment with a carrying value of $3.4 million (December 31, 2011 − $4.1 million). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at its fair value of $1.3 million at September 30, 2012 (December 31, 2011 – $1.0 million). This investment is classified as an available-for-sale investment. The total carrying value of investments in new business ventures at September 30, 2012 and December 31, 2011, is $4.7 million and $5.1 million, respectively, and is recorded in Other Assets.
ASC 320	The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) and ASC 320 − “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate. At September 30, 2012, the equity method of accounting is being utilized for an investment with a carrying value of $3.4 million (December 31, 2011 − $4.1 million). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at its fair value of $1.3 million at September 30, 2012 (December 31, 2011 – $1.0 million). This investment is classified as an available-for-sale investment. The total carrying value of investments in new business ventures at September 30, 2012 and December 31, 2011, is $4.7 million and $5.1 million, respectively, and is recorded in Other Assets.
ASU No. 2011-04	In May 2011, the FASB issued ASU No. 2011-04, “Fair Value Measurement (ASC Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs” (“ASU 2011-04”). The standards set forth in ASU 2011-04 supersede most of the accounting guidance currently found in Topic 820 of the FASB's ASC. The amendments will improve comparability of fair value measurements presented and disclosed in financial statements prepared with U.S. GAAP and International Financial Reporting Standards (“IFRS”). The amendments also clarify the application of existing fair value measurement requirements. These amendments include (1) the application of the highest and best use and valuation premise concepts, (2) measuring the fair value of an instrument classified in a reporting entity's shareholders' equity and (3) disclosing quantitative information about the unobservable inputs used within the Level 3 hierarchy. For public entities, the amendments are effective for interim and annual periods beginning after December 15, 2011 on a prospective basis. Early application by public entities is not permitted. On January 1, 2012, the Company adopted the disclosure requirements amendments in ASU 2011-04 relating to Level 3 fair value measurements and accordingly, has expanded disclosures as presented in note 17(b).
Condition for Company's policy to review and assess collectability on theater's past due accounts	The Company's net investment in leases and its net financed sale receivables are subject to the disclosure requirements of ASC 310 “Receivables.” Due to differing risk profiles of its net investment in leases and its net financed sales receivables, the Company views its net investment in leases and its net financed sale receivables as separate classes of financing receivables. The Company does not aggregate financing receivables to assess impairment. The Company monitors the credit quality of each customer on a frequent basis through collections and aging analyses. The Company also holds meetings monthly in order to identify credit concerns and whether a change in credit quality classification is required for the customer. A customer may improve in their credit quality classification once a substantial payment is made on overdue balances or the customer has agreed to a payment plan with the Company and payments have commenced in accordance to the payment plan. The change in credit quality indicator is dependant upon management approval. The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only: Good standing — Theater continues to be in good standing with the Company as the client's payments and reporting are up-to-date. Credit Watch — Theater operator has begun to demonstrate a delay in payments, has been placed on the Company's credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance, length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "Pre-approved transactions" category, but not in as good of condition as those receivables in "Good standing." Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the "all transactions suspended" category, but not in as good of condition as those receivables in "Credit Watch." Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired. All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended”, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped. While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income. During the quarter ended September 30, 2012, a financing receivable was modified as a troubled debt restructuring. The customer has paid all overdue amounts in accordance with such restructuring which has resulted in a change in the credit quality classification from 'pre-approved transactions' to 'in good standing'. The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater's aging exceeds 90 days, the Company's policy is to review and assess collectibility on the theater's past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.
Accounting Pronouncements Not Yet Adopted	In December 2011, the FASB issued ASU No. 2011-11, “Balance Sheet - Disclosures about Offsetting Assets and Liabilities (ASC Topic 210)”. The purpose of the amendment is to provide greater clarity within disclosures between entities reporting in U.S. GAAP versus IFRS that have offsetting (netting) assets and liabilities. Entities will be required to disclose both gross information and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. An entity is required to apply the amendments in ASU 2011-11 for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. It is to be applied retrospectively for all comparative periods presented. The Company is currently evaluating the potential impact of ASU 2011-11 on its condensed consolidated financial statements.

- Definition

Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759159-111685

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=7880789&loc=d3e5728-111685

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 2AA
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=7880789&loc=SL6759068-111685

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 24
-Subparagraph e
-Appendix D

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22E
-Subparagraph a
-Appendix D

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Paragraph 22B
-Subparagraph a
-Appendix D

+ Details

- Definition

Disclosure of accounting policy for the equity method of accounting for investments in common stock or other interests including unconsolidated domestic subsidiaries, corporate joint ventures, noncontrolling interests in real estate ventures, limited partnerships, and limited liability companies. Additionally, this element describes the entity's application of the cost method to equity investments or other interests that are not consolidated or accounted for under the equity method of accounting. The disclosure provided may include how equity method or cost investments are assessed for impairment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6872113&loc=d3e27290-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 19
-Subparagraph h
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 10, 11, 12, 13, 15, 17, 18
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 12
-Article 5

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 5, 6, 7, 16-19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Disclosure of accounting policy for investments in debt and equity securities that are classified as available-for-sale. This policy also may describe the entity's accounting treatment for transfers between investment categories, how the entity determines whether impairments of available-for-sale securities are other than temporary, and how the fair values of such securities are determined.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196929

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10, 11
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section M

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 115
-Paragraph 12, 13, 14, 15, 16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 2, 12
-Article 5

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS115-1/124-1
-Paragraph 7, 8, 9, 13, 14, 15, 16, 17
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Financing Receivables (Tables)

9 Months Ended

Sep. 30, 2012

Financing Receivables [Abstract]

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales

	September 30,		December 31,
	2012		2011
Gross minimum lease payments receivable	$	19,340	$	29,603
Unearned finance income		(4,888)		(8,356)
Minimum lease payments receivable		14,452		21,247
Accumulated allowance for uncollectible amounts		(1,130)		(1,833)
Net investment in leases		13,322		19,414
Gross financed sales receivables		110,508		95,686
Unearned finance income		(32,231)		(28,070)
Financed sales receivables		78,277		67,616
Accumulated allowance for uncollectible amounts		(66)		(316)
Net financed sales receivables		78,211		67,300
Total financing receivables	$	91,533	$	86,714

Net financed sales receivables due within one year	$	9,851	$	8,694
Net financed sales receivables due after one year	$	68,360	$	58,606

Inventories (Tables)

9 Months Ended

Sep. 30, 2012

Inventories [Abstract]

Inventories

	September 30,		December 31,
	2012		2011
Raw materials	$	7,409	$	5,803
Work-in-process		1,226		1,515
Finished goods		12,206		12,429
	$	20,841	$	19,747

Property Plant and Equipment (Tables)

9 Months Ended

Sep. 30, 2012

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

		As at September 30, 2012
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components⁽¹⁾⁽²⁾	$	126,549	$	39,142	$	87,407
	Camera equipment⁽⁵⁾		4,493		4,286		207
			131,042		43,428		87,614
Assets under construction⁽³⁾			9,005		-		9,005
Other property, plant and equipment
	Land		1,593		-		1,593
	Buildings		14,633		9,724		4,909
	Office and production equipment⁽⁴⁾		23,550		18,955		4,595
	Leasehold improvements		9,715		8,316		1,399
			49,491		36,995		12,496
		$	189,538	$	80,423	$	109,115

		As at December 31, 2011
				Accumulated		Net Book
		Cost		Depreciation		Value
Equipment leased or held for use
	Theater system components⁽¹⁾⁽²⁾	$	122,691	$	39,773	$	82,918
	Camera equipment⁽⁵⁾		6,355		6,088		267
			129,046		45,861		83,185
Assets under construction⁽³⁾			4,972		-		4,972
Other property, plant and equipment
	Land		1,593		-		1,593
	Buildings		14,633		9,352		5,281
	Office and production equipment⁽⁴⁾		29,220		24,772		4,448
	Leasehold improvements		9,396		7,622		1,774
			54,842		41,746		13,096
		$	188,860	$	87,607	$	101,253

Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2012

Other Intangible Assets [Abstract]

Other Intangible Assets


	As at September 30, 2012
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	8,293	$	5,556	$	2,737
Licenses and intellectual property		19,750		1,358		18,392
Other		6,580		-		6,580
	$	34,623	$	6,914	$	27,709

	As at December 31, 2011
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	8,014	$	5,304	$	2,710
Licenses and intellectual property		19,407		254		19,153
Other		3,050		-		3,050
	$	30,471	$	5,558	$	24,913

Credit Facility (Tables)

9 Months Ended

Sep. 30, 2012

Credit Facility [Abstract]

Bank indebtedness

	September 30,		December 31,
	2012		2011

Revolving Term Loan	$	30,000	$	55,083

Term loan principal payments

2012 (three months remaining)	$	-
2013		-
2014		-
2015		30,000
2016		-
Thereafter		-
	$	30,000

Commitments (Tables)

9 Months Ended

Sep. 30, 2012

Commitments, Contingencies and Guarantees [Abstract]

Total minimum annual rental payments under lease

	Operating Leases		Capital Leases
2012 (three months remaining)	$	1,750	$	6
2013		6,584		20
2014		5,578		-
2015		1,286		-
2016		511		-
Thereafter		1,323		-
	$	17,032	$	26

Contingencies and Guarantees (Tables)

9 Months Ended

Sep. 30, 2012

Commitments, Contingencies and Guarantees [Abstract]

Accrual for product warranties

	September 30,		December 31,
	2012		2011
Balance at the beginning of period	$	94	$	160
Warranty redemptions		(66)		(152)
Warranties issued		28		146
Revisions		(48)		(60)
Balance at the end of period	$	8	$	94

Condensed Consolidated Statements of Cash Flows Supplemental Information (Tables)

9 Months Ended

Sep. 30, 2012

Condensed Consolidated Statements of Cash Flows Supplemental Information [Abstract]

Changes in other non-cash operating assets and liabilities

		Nine Months
		Ended September 30,
		2012		2011
Decrease (increase) in:
	Accounts receivable	$	9,915	$	(1,224)
	Financing receivables		(4,900)		(8,471)
	Inventories		(4,169)		(5,274)
	Prepaid expenses		(955)		(1,548)
	Commissions and other deferred selling expenses		113		(44)
	Insurance recoveries		138		1,202
	Other assets		(1,313)		(1,659)
Increase (decrease) in:
	Accounts payable		(11,174)		(6,376)
	Accrued and other liabilities⁽¹⁾		(1,528)		(31,027)
	Deferred revenue		5,201		6,229
		$	(8,672)	$	(48,192)

Cash payments

	(b) Cash payments made on account of:
		Nine Months
		Ended September 30,
		2012		2011
Income taxes		$	977	$	2,201
Interest		$	1,181	$	878

Summary of depreciation and amortization

	(c) Depreciation and amortization are comprised of the following:
		Nine Months
		Ended September 30,
			2012		2011
Film assets		$	12,131	$	9,373
Property, plant and equipment
	Joint revenue sharing arrangements		7,384		4,914
	Other property, plant and equipment		3,186		2,866
Other intangible assets			1,507		341
Other assets			368		181
Deferred financing costs			128		345
		$	24,704	$	18,020

Write downs, net of recoveries

	(d) Write-downs, net of recoveries, are comprised of the following:
		Nine Months
		Ended September 30,
			2012		2011

Accounts receivables		$	674	$	433
Financing receivables			155		334
Inventories⁽¹⁾			503		-
Impairment of available-for-sale investment			150		-
Property, plant and equipment			18		74
Other intangible assets			11		-
Other assets			5		-
		$	1,516	$	841

Receivable Provisions Net of Recoveries (Tables)

9 Months Ended

Sep. 30, 2012

Receivable Provisions, Net of Recoveries [Abstract]

Receivable Provisions, Net of Recoveries

	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2012		2011		2012		2011
Accounts receivable provisions, net of recoveries	$	241	$	163	$	674	$	433
Financing receivables, net of recoveries		-		245		155		334
Receivable provisions, net of recoveries	$	241	$	408	$	829	$	767

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2012

Income Taxes [Abstract]

Income Tax Effect on Comprehensive Income

	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2012		2011		2012		2011

Amortization of actuarial loss on defined benefit plan	$	(23)	$	(13)	$	(69)	$	(40)
Change in market value of available-for-sale investment		-		-		(42)		61
Other-than-temporary impairment of available-for-sale investment		-		-		(19)		-
Unrealized change in cash flow hedging instruments		(153)		344		(213)		248
Realization of cash flow hedging gains upon settlement		42		21		7		219
	$	(134)	$	352	$	(336)	$	488

Capital Stock (Tables)

9 Months Ended

Sep. 30, 2012

Capital Stock [Abstract]

Weighted average fair value of common share granted to employees

	Three Months Ended September 30,		Nine Months Ended September 30,
	2012	2011	2012	2011

Average risk-free interest rate	1.07%	2.35%	1.38%	2.79%
Expected option life (in years)	5.29 - 5.30	5.12 - 5.15	2.89 - 5.36	1.78 - 5.15
Expected volatility	50%	50%	50%	50%
Annual termination probability	8.52% - 8.76%	8.31%	0% - 8.76%	0% - 8.49%
Dividend yield	0%	0%	0%	0%

Option activity under the Stock Option Plan

				Weighted Average Exercise
	Number of Shares			Price Per Share
	2012	2011	2012		2011

Options outstanding, beginning of year	7,200,721	6,743,272	$	14.60	$	10.79
Granted	1,686,862	1,122,342		24.78		31.79
Exercised	(924,579)	(528,485)		6.31		10.66
Forfeited	(154,958)	(141,600)		23.03		19.68
Expired	-	-		-		-
Cancelled	(4,120)	-		33.73		-
Options outstanding, end of period	7,803,926	7,195,529		17.61		13.90
Options exercisable, end of period	3,706,631	3,607,049		13.80		9.19

Options to Non-Employees

	Three Months		Nine Months
	Ended September 30,		Ended September 30,
	2012	2011	2012	2011

Average risk-free interest rate	n/a	n/a	1.28%	2.38%
Contractual option life	n/a	n/a	7 Years	6 years
Average expected volatility	n/a	n/a	50%	50%
Dividend yield	n/a	n/a	0%	0%

Fair value measurement of stock appreciation rights

	As at September 30, 2012	As at December 31, 2011

Average risk-free interest rate	0.62%	1.09%
Expected option life (in years)	2.69 - 2.77	3.18 - 3.46
Expected volatility	50%	50%
Annual termination probability	8.76%	8.76%
Dividend yield	0%	0%

Basic and diluted per-share computations

	Three Months					Nine Months
	Ended September 30,					Ended September 30,
	2012		2011		2012		2011

Net income from operations applicable to common shareholders	$	14,990	$	8,392	$	28,658	$	9,214
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period		65,893		64,568		65,053		64,146
Weighted average number of shares issued during the period		37		86		665		260
Weighted average number of shares used in computing basic income per share		65,930		64,654		65,718		64,406
Assumed exercise of stock options, net of shares assumed		2,371		3,102		2,469		3,704
Weighted average number of shares used in computing diluted income per share		68,301		67,756		68,187		68,110

Movement of Shareholders' Equity

Balance as at December 31, 2011		$	192,907
Issuance of common shares for stock options exercised			5,831
Net income			28,658
Adjustments to other equity:
	Employee stock options granted		9,841
	Non-employee stock options granted		115
	Stock options exercised		(879)
Adjustment to capital stock for stock options exercised			879
Adjustments to accumulated other comprehensive loss:
	Unrealized net gain from cash flow hedging instruments		826
	Realization of cash flow hedging net gain upon settlement		(22)
	Amortization of actuarial loss on defined benefit plan		273
	Change in market value of available-for-sale investment		338
	Other-than-temporary impairment of available-for-sale investment		150
	Tax effect of movement in accumulated other comprehensive income		(336)
Balance as at September 30, 2012		$	238,581

Segment Information (Tables)

9 Months Ended

Sep. 30, 2012

Segmented Information [Abstract]

Inter-segment revenue

		Three Months				Nine Months
		Ended September 30,				Ended September 30,
			2012		2011	2012		2011
Revenue⁽¹⁾
IMAX systems		$	25,358	$	20,649	$	59,063	$	63,378
Theater system maintenance			7,042		6,348		20,878		18,270
Joint revenue sharing arrangements			13,186		9,995		40,477		22,382
Films
	Production and IMAX DMR		25,223		18,600		58,805		38,280
	Distribution		3,259		4,965		11,122		12,857
	Post-production		1,646		3,023		5,778		5,686
Other			4,997		3,908		10,394		9,027
Total		$	80,711	$	67,488	$	206,517	$	169,880

Gross margins
IMAX systems⁽²⁾		$	15,956	$	13,294	$	34,475	$	36,469
Theater system maintenance			2,828		1,944		8,122		6,912
Joint revenue sharing arrangements⁽²⁾			9,286		6,733		28,340		13,792
Films
	Production and IMAX DMR⁽²⁾		15,426		12,015		35,714		21,235
	Distribution⁽²⁾		587		1,418		2,133		2,531
	Post-production		103		808		1,373		2,804
Other			564		226		287		(357)
Total		$	44,750	$	36,438	$	110,444	$	83,386

		September 30,		December 31,
			2012		2011
Assets
IMAX systems		$	155,107	$	154,312
Theater system maintenance			13,376		13,008
Joint revenue sharing arrangements			123,404		120,483
Films
	Production and IMAX DMR		10,628		16,577
	Distribution		6,737		4,504
	Post-production		4,064		4,185
Other			3,095		2,718
Corporate and other non-segment specific assets			110,624		90,449
Total		$	427,035	$	406,236


	Three Months				Nine Months
	Ended September 30,				Ended September 30,
		2012		2011		2012		2011
Revenue
United States	$	38,897	$	30,030	$	98,007	$	82,713
Asia (excluding Greater China)		8,822		6,252		18,687		13,735
Russia and the CIS		7,994		2,804		14,615		13,620
Greater China		7,567		7,949		29,002		17,893
Canada		6,357		6,846		14,289		13,314
Rest of the World		5,212		6,281		13,778		9,074
Western Europe		4,426		6,078		15,201		14,758
Rest of Europe		775		626		1,396		3,334
Mexico		661		622		1,542		1,439
Total	$	80,711	$	67,488	$	206,517	$	169,880

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details

Employees Pension and Postretirement Benefits (Tables)

9 Months Ended

Sep. 30, 2012

Defined Benefit Plan Disclosure [Line Items]

Amounts accrued

	September 30,		December 31,
	2012		2011

Obligation, beginning of period	$	18,990	$	18,108
Interest cost		204		279
Actuarial loss		-		603
Obligation, end of period and unfunded status	$	19,194	$	18,990

Pension Expense

	The following table provides disclosure of pension expense for the SERP:

		Three Months Ended September 30,				Nine Months Ended September 30,
		2012		2011		2012		2011
Interest cost		$	68	$	69	$	204	$	209
Amortization of actuarial loss			91		53		273		161
Pension expense		$	159	$	122	$	477	$	370

Pension Plans, Defined Benefit [Member]

Defined Benefit Plan Disclosure [Line Items]

Components of net periodic benefit cost

	As at		As at
	September 30,		December 31,
	2012		2011

Unrecognized actuarial loss	$	2,355	$	2,628

Schedule of expected benefit payments

2012 (three months remaining)	$	-
2013		-
2014		19,676
2015		-
2016		-
Thereafter		-
	$	19,676

Other Postretirement Benefit Plans, Defined Benefit [Member]

Defined Benefit Plan Disclosure [Line Items]

Schedule of expected benefit payments

2012 (three months remaining)	$	15
2013		16
2014		35
2015		38
2016		42
Thereafter		407
	$	553

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2012

Financial Instruments [Abstract]

Fair Value of Financial Instruments

		As at September 30, 2012				As at December 31, 2011
		Carrying		Estimated		Carrying		Estimated
		Amount		Fair Value		Amount		Fair Value
Borrowings under Credit Facility	$	(30,000)	$	(30,000)	$	(55,083)	$	(55,083)
Net financed sales receivable	$	78,211	$	75,925	$	67,300	$	65,846
Net investment in sales-type leases	$	13,322	$	13,730	$	19,414	$	20,448
Available-for-sale investment	$	1,350	$	1,350	$	1,012	$	1,012
Foreign exchange contracts — designated forwards	$	621	$	621	$	(182)	$	(182)
Foreign exchange contracts — non-designated forwards	$	345	$	345	$	(645)	$	(645)

Summary of changes in the fair value


			Available For Sale Investments
			2012		2011

Beginning balance, January 1,			$	1,012	$	1,500
	Transfers into/out of Level 3			-		-
	Total gains or losses (realized/unrealized)
		Included in earnings		-		-
		Change in other comprehensive income		338		(488)
	Purchases, issuances, sales and settlements			-		-
Ending balance, September 30,			$	1,350	$	1,012

The amount of total gains or losses for the period included in earnings attributable to the
	change in unrealized gains or losses relating to assets still held at the reporting date		$	(150)	$	-

Recorded Investment in Financing Receivables

	As at September 30, 2012						As at December 31, 2011
	Minimum		Financed				Minimum		Financed
	Lease		Sales				Lease		Sales
	Payments		Receivables		Total		Payments		Receivables		Total

In good standing	$	11,318	$	70,027	$	81,345	$	15,667	$	55,907	$	71,574
Credit watch		187		7,272		7,459		1,506		3,718		5,224
Pre-approved transactions		783		296		1,079		1,837		7,272		9,109
Transactions suspended		2,164		682		2,846		2,237		719		2,956
	$	14,452	$	78,277	$	92,729	$	21,247	$	67,616	$	88,863

Investment In Financing Receivables On Nonaccrual Status


	As at September 30, 2012				As at December 31, 2011
	Recorded		Related		Recorded		Related
	Investment		Allowance		Investment		Allowance

Net investment in leases	$	2,947	$	(1,130)	$	4,692	$	(1,833)
Net financed sales receivables		978		(66)		1,329		(316)
	$	3,925	$	(1,196)	$	6,021	$	(2,149)

Aging of Financing Receivables


	As at September 30, 2012
									Related						Recorded
							Billed		Unbilled		Total				Investment
							Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	208	$	95	$	1,143	$	1,446	$	13,006	$	14,452	$	(1,130)	$	13,322
Net financed sales receivables		1,125		549		1,037		2,711		75,566		78,277		(66)		78,211
Total	$	1,333	$	644	$	2,180	$	4,157	$	88,572	$	92,729	$	(1,196)	$	91,533



	As at December 31, 2011
									Related						Recorded
							Billed		Unbilled		Total				Investment
							Financing		Recorded		Recorded		Related		Net of
	Current		30-89 Days		90+ Days		Receivables		Investment		Investment		Allowances		Allowances

Net investment in leases	$	350	$	261	$	1,754	$	2,365	$	18,882	$	21,247	$	(1,833)	$	19,414
Net financed sales receivables		723		593		1,029		2,345		65,270		67,616		(316)		67,300
Total	$	1,073	$	854	$	2,783	$	4,710	$	84,152	$	88,863	$	(2,149)	$	86,714

Financing receivables continues to accrue finance income

	As at September 30, 2012
									Related				Recorded
							Billed		Unbilled				Investment
							Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	7	$	14	$	21	$	42	$	145	$	-	$	187
Net financed sales receivables		239		314		649		1,202		15,284		-		16,486
Total	$	246	$	328	$	670	$	1,244	$	15,429	$	-	$	16,673


	As at December 31, 2011
									Related				Recorded
							Billed		Unbilled				Investment
							Financing		Recorded		Related		Past Due
	Current		30-89 Days		90+ Days		Receivables		Investment		Allowance		and Accruing

Net investment in leases	$	67	$	118	$	144	$	329	$	3,766	$	-	$	4,095
Net financed sales receivables		202		345		674		1,221		16,343		-		17,564
Total	$	269	$	463	$	818	$	1,550	$	20,109	$	-	$	21,659

Impaired financing receivables

		For the Three Months Ended September 30, 2012
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		671		195		(66)		671		-

Recorded investment for which there is no related allowance:
	Net financed sales receivables		385		19		-		474		11

Total recorded investment in impaired loans:
	Net financed sales receivables	$	1,056	$	214	$	(66)	$	1,145	$	11

		For the Three Months Ended September 30, 2011
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		225		208		(66)		227		-

Total recorded investment in impaired loans:
	Net financed sales receivables	$	225	$	208	$	(66)	$	227	$	-

		For the Nine Months Ended September 30, 2012
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		671		195		(66)		204		-

Recorded investment for which there is no related allowance:
	Net financed sales receivables		385		19		-		512		11

Total recorded investment in impaired loans:
	Net financed sales receivables	$	1,056	$	214	$	(66)	$	716	$	11

		For the Nine Months Ended September 30, 2011
								Average		Interest
		Recorded		Unpaid		Related		Recorded		Income
		Investment		Principal		Allowance		Investment		Recognized
Recorded investment for which there is a related allowance:
	Net financed sales receivables		225		208		(66)		235		-

Total recorded investment in impaired loans:
	Net financed sales receivables	$	225	$	208	$	(66)	$	235	$	-

Allowance for credit losses and investment in financing receivables

		Three Months Ended September 30, 2012					Nine Months Ended September 30, 2012
		Net Investment		Net Financed			Net Investment		Net Financed
		in Leases		Sales Receivables			in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance		$	1,892	$	173		$	1,833	$	316
	Charge-offs		(762)		(107)	⁽¹⁾		(1,019)		(109)	⁽¹⁾
	Provision		-		-			316		(141)
Ending balance		$	1,130	$	66		$	1,130	$	66

Ending balance: individually evaluated for impairment		$	1,130	$	66		$	1,130	$	66

Financing receivables:

Ending balance: individually evaluated for impairment		$	14,452	$	78,277		$	14,452	$	78,277


		Three Months Ended September 30, 2011					Nine Months Ended September 30, 2011
		Net Investment		Net Financed			Net Investment		Net Financed
		in Leases		Sales Receivables			in Leases		Sales Receivables
Allowance for credit losses:

Beginning balance		$	2,592	$	66		$	4,838	$	66
	Charge-offs		(363)		-			(2,808)		-
	Provision		320		-			519		-
Ending balance		$	2,549	$	66		$	2,549	$	66

Ending balance: individually evaluated for impairment		$	2,549	$	66		$	2,549	$	66



Financing receivables:

Ending balance: individually evaluated for impairment		$	22,000	$	61,939		$	22,000	$	61,939

Notional amount of derivative

		September 30,		December 31,
			2012		2011
Derivatives designated as hedging instruments:
	Foreign exchange contracts - Forwards	$	13,500	$	20,581

Derivatives not designated as hedging instruments:
	Foreign exchange contracts - Forwards		7,274		67,341
		$	20,774	$	87,922

Fair value of foreign exchange contracts

			September 30,		December 31,
		Balance Sheet Location	2012		2011
Derivatives designated as hedging instruments:
	Foreign exchange contracts — Forwards	Other Assets (Accrued liabilities)	$	621	$	(182)

Derivatives not designated as hedging instruments:
	Foreign exchange contracts — Forwards	Other Assets (Accrued liabilities)		345		(645)
			$	966	$	(827)

Derivatives in Foreign Currency Hedging relationships

		Three Months Ended September 30,				Nine Months Ended September 30,
			2012		2011		2012		2011
Foreign exchange contracts - Forwards	Derivative Gain (Loss) Recognized in OCI (Effective Portion)	$	589	$	(1,151)	$	826	$	(800)
		$	589	$	(1,151)	$	826	$	(800)

	Location of Derivative
	Gain Reclassified from
	AOCI into Income	Three Months Ended September 30,				Nine Months Ended September 30,
	(Effective Portion)		2012		2011		2012		2011
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	158	$	229	$	22	$	953
		$	158	$	229	$	22	$	953

Non Designated Derivatives in Foreign Currency relationships

		Three Months Ended September 30,				Nine Months Ended September 30,
	Location of Derivative Gain (Loss)		2012		2011		2012		2011
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	400	$	(3,893)	$	1,229	$	(3,172)
		$	400	$	(3,893)	$	1,229	$	(3,172)

Basis of Presentation (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Basis of Presentation (Details) - USD ($) $ in Millions	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Basis of Presentation (Textuals) [Abstract]
Carrying value of equity investments	$ 3.4		$ 3.4		$ 4.1
Investment in preferred stock of other business venture	1.3		1.3		1.0
Total assets	14.8		14.8
Total carrying value of investments in new business ventures	4.7		4.7		5.1
Cost of available for sale securities	1.5		$ 1.5		1.5
Number Of Variable Interest Entities			9
Number Of Variable Interest Entities Primary Beneficiary			2
Number Of Variable Interest Entities Not A Primary Beneficiary			7
Basis of Presentation (Additional Textuals) [Abstract]
Variable interest entity, Assets	0.0		$ 0.0		0.0
Variable interest entity, Liabilities	0.0		0.0		0.0
Variable Interest Entity, Primary Beneficiary [Member]
Basis of Presentation (Textuals) [Abstract]
Loss exposure	0.3		0.3
Variable Interest Entity, Not Primary Beneficiary [Member]
Basis of Presentation (Textuals) [Abstract]
Carrying value of investments	0.0		0.0		0.0
Carrying value of equity investments	3.4		3.4		4.1
Total assets	14.8		14.8		12.7
Total liabilities	14.8		14.8		$ 12.7
Earnings of the investees	$ 0.0	$ 0.0	$ 0.0	$ 0.0

Financing Receivables (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales
Gross minimum lease payments receivable	$ 19,340	$ 29,603
Unearned finance income	(4,888)	(8,356)
Minimum lease payments receivable	14,452	21,247
Accumulated allowance for uncollectible amounts	(1,130)	(1,833)
Net investment in leases	13,322	19,414
Gross financed sales receivables	110,508	95,686
Unearned finance income	(32,231)	(28,070)
Financed sales receivables	78,277	67,616
Accumulated allowance for uncollectible amounts	(66)	(316)
Net financed sales receivables	78,211	67,300
Total financing receivables	91,533	86,714
Net financed sales receivables due within one year	9,851	8,694
Net financed sales receivables due after one year	$ 68,360	$ 58,606
Financing Receivables (Textuals) [Abstract]
Financed sale receivables, Weighted average effective interest rate	9.10%	8.90%

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Inventories
Raw materials	$ 7,409	$ 5,803
Work-in-process	1,226	1,515
Finished goods	12,206	12,429
Total	20,841	19,747
Inventories (Textuals) [Abstract]
Finished goods inventory with title passed to customer	5,000	5,700
Provision for excess and obsolete inventory	$ 4,500	$ 4,000

- Definition

The amount of the valuation account as of the balance sheet date which reduces the carrying amount of inventory to net realizable value; takes into consideration such factors as market value, excessive quantities based on expected sales, technological obsolescence, and shrinkage. May also provide for estimated product returns or price concessions pertaining to product cost.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.BB)
-URI http://asc.fasb.org/extlink&oid=6386940&loc=d3e100047-122729

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e24092-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Paragraph 14
-Chapter 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Paragraph 8, 9, 14
-Chapter 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Section A
-Paragraph 9
-Chapter 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 09
-Article 12

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 6
-Subparagraph a
-Article 5

+ Details

Property Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Property, plant and equipment
Cost	$ 189,538	$ 188,860
Accumulated Depreciation	80,423	87,607
Net Book Value	109,115	101,253
Other property, plant and equipment [Member]
Property, plant and equipment
Cost	49,491	54,842
Accumulated Depreciation	36,995	41,746
Net Book Value	12,496	13,096
Land [Member]
Property, plant and equipment
Cost	1,593	1,593
Accumulated Depreciation	0	0
Net Book Value	1,593	1,593
Building [Member]
Property, plant and equipment
Cost	14,633	14,633
Accumulated Depreciation	9,724	9,352
Net Book Value	4,909	5,281
Equipment [Member]
Property, plant and equipment
Cost	23,550	29,220
Accumulated Depreciation	18,955	24,772
Net Book Value	4,595	4,448
Leasehold Improvements [Member]
Property, plant and equipment
Cost	9,715	9,396
Accumulated Depreciation	8,316	7,622
Net Book Value	1,399	1,774
Asset under Construction [Member]
Property, plant and equipment
Cost	9,005	4,972
Accumulated Depreciation	0	0
Net Book Value	9,005	4,972
Equipment leased or held for use [Member]
Property, plant and equipment
Cost	131,042	129,046
Accumulated Depreciation	43,428	45,861
Net Book Value	87,614	83,185
Theater System Components [Member]
Property, plant and equipment
Cost	126,549	122,691
Accumulated Depreciation	39,142	39,773
Net Book Value	87,407	82,918
Camera Equipment [Member]
Property, plant and equipment
Cost	4,493	6,355
Accumulated Depreciation	4,286	6,088
Net Book Value	$ 207	$ 267

Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Other Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Other Intangible Assets
Other Intangible Assets, Cost	$ 34,623		$ 34,623		$ 30,471
Other Intangible Assets, Accumulated Amortization	6,914		6,914		5,558
Other Intangible Assets, Net Book Value	$ 27,709		27,709		24,913
Other Intangible Assets (Textuals) [Abstract]
Costs incurred to renew or extend the term of acquired other intangible assets			100	$ 100
Costs incurred to renew or extend the term of acquired other intangible assets	less than $100,000	less than $100,000
Other Intangible Assets (Additional Textuals) [Abstract]
Approximate amortization expense of other intangible assets for the remainder of 2012	$ 500		500
2013	2,000		2,000
2014	2,000		2,000
2015	2,000		2,000
2016	2,000		2,000
2017	2,000		2,000
Acquisition of patents and Trademarks, cost	4,300		4,300
Acquisition of patents and Trademarks, net book value	4,200		$ 4,200
Weighted average amortization period for additions to other intangible assets			10 years
Patents and Trademarks [Member]
Other Intangible Assets
Other Intangible Assets, Cost	8,293		$ 8,293		8,014
Other Intangible Assets, Accumulated Amortization	5,556		5,556		5,304
Other Intangible Assets, Net Book Value	2,737		2,737		2,710
Other Finite Lived Assets [Member]
Other Intangible Assets
Other Intangible Assets, Cost	19,750		19,750		19,407
Other Intangible Assets, Accumulated Amortization	1,358		1,358		254
Other Intangible Assets, Net Book Value	18,392		18,392		19,153
Other Intangibles [Member]
Other Intangible Assets
Other Intangible Assets, Cost	6,580		6,580		3,050
Other Intangible Assets, Accumulated Amortization	0		0		0
Other Intangible Assets, Net Book Value	$ 6,580		$ 6,580		$ 3,050

Credit Facility (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Credit Facility (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011	Jun. 02, 2011	Nov. 16, 2009
Bank indebtedness
Bank indebtedness (note 7)	$ 30,000		$ 30,000		$ 55,083
Credit Facility (Textuals) [Abstract]
Maximum borrowing capacity						$ 110,000
Credit Facility Description			maximum aggregate borrowings equal to the lesser of: (i) $50.0 million, and (ii) a collateral calculation based on the percentages of the book values of certain of the Company’s net investment in sales-type leases, financing receivables, certain trade accounts receivable, finished goods inventory allocated to backlog contracts and the appraised values of the expected future cash flows related to operating leases and the Company’s owned real property, reduced by certain accruals and accounts payable and subject to other conditions, limitations and reserve right requirements.
Revolving portion of the credit facility			at the Company’s option, at (i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% per annum
Actual Excess Availability	55,000		$ 55,000
Letters of credit and advance payment guarantees	0		0		3,000
Notional Amount of arrangements entered into	20,800		20,800
Minimum cash and excess availability	84,450		$ 84,450
Additional Credit Facility (Textuals) [Abstract]
Line of credit facility covenant terms			The Credit Facility provides that the Company will be required to maintain a ratio of funded debt (as defined in the Credit Agreement) to EBITDA (as defined in the Credit Agreement) of not more than 2:1. The Company will also be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1.0. At all times under the terms of the Credit Facility, the Company is required to maintain minimum Excess Availability of not less than $5.0 million and minimum Cash and Excess Availability of not less than $15.0 million. These amounts were $55.0 million and $84.4 million at September 30, 2012 respectively. The Company was in compliance with all of these requirements at September 30, 2012.
Amounts drawn under credit facility	30,000		$ 30,000		55,083
Wells Fargo Foreign Exchange Facility [Member]
Credit Facility (Textuals) [Abstract]
Notional Amount of arrangements entered into	20,800		20,800
Settlement risk on its foreign currency forward contracts	0		0
Wells Fargo Foreign Exchange Facility [Member] \| Letter Of Credit And Apg [Member]
Credit Facility (Textuals) [Abstract]
Amounts drawn	0		0
Bank of Montreal Facilities [Member] \| Letter Of Credit And Apg [Member]
Credit Facility (Textuals) [Abstract]
Line of Credit Facility, Remaining Borrowing Capacity	10,000		10,000		10,000
Amounts drawn	900		900		800
Prior Credit Facility [Member]
Credit Facility (Textuals) [Abstract]
Maximum borrowing capacity							$ 75,000
Prior Credit Facility [Member] \| Revolving Loan [Member]
Credit Facility (Textuals) [Abstract]
Effective interest rate				2.97%
Prior Credit Facility [Member] \| Term Loan [Member]
Credit Facility (Textuals) [Abstract]
Effective interest rate				4.04%
Credit Facility [Member]
Credit Facility (Textuals) [Abstract]
Actual Excess Availability	5,000		5,000
Line of Credit Facility, Remaining Borrowing Capacity	80,000		80,000		52,000
Amounts drawn	30,000		30,000		55,083
Minimum cash and excess availability	15,000		15,000
Minimum excess availability reserve	$ 5,000		$ 5,000
Credit Facility [Member] \| Revolving Asset Based Loans [Member]
Credit Facility (Textuals) [Abstract]
Maximum borrowing capacity						50,000
Revolving portion of the credit facility	(i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% Per annum		(i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% Per annum
Amounts drawn	$ 0		$ 0
Current borrowing capacity	50,000		50,000		47,100
Settlement risk on its foreign currency forward contracts
Minimum excess availability reserve	5,000		5,000
Credit Facility [Member] \| Revolving Term Loan [Member]
Bank indebtedness
Bank indebtedness (note 7)	$ 30,000		$ 30,000		55,083
Credit Facility (Textuals) [Abstract]
Maximum borrowing capacity						60,000
Effective interest rate	2.39%	2.69%	2.41%	2.59%
Revolving portion of the credit facility	(i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% Per annum			(i) LIBOR plus a margin of 2.00% per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% Per annum
Amounts drawn	$ 30,000		$ 30,000
Current borrowing capacity	30,000		30,000
Additional Credit Facility (Textuals) [Abstract]
Amounts drawn under credit facility	$ 30,000		$ 30,000		$ 55,083
Credit Facility [Member] \| Letter of Credit [Member]
Credit Facility (Textuals) [Abstract]
Maximum borrowing capacity						$ 20,000

Commitments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Commitments (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Total minimum annual rental payments under operating lease
2012 (three months remaining), Operating Leases	$ 1,750		$ 1,750
2012 (three months remaining), Capital Leases	6		6
2013, Operating Leases	6,584		6,584
2013, Capital Leases	20		20
2014, Operating Leases	5,578		5,578
2014, Capital Leases	0		0
2015, Operating Leases	1,286		1,286
2015, Capital Leases	0		0
2016, Operating Leases	511		511
2016, Capital Leases	0		0
Thereafter, Operating Leases	1,323		1,323
Thereafter, Capital Leases	0		0
Operating Leases, Total	17,032		17,032
Capital Leases, Total	26		26
Commitments (Textuals) [Abstract]
Rent expense, Total	1,500	$ 1,300	4,600	$ 3,500
Rent expense, sublease rental	0	$ 0	0
Rent expense, sublease rental				less than $100,000
Accrued rent and lease inducements recognized as an offset to rent expense included in Accrued liabilities	2,600		2,600		$ 3,500
Purchase obligation under long term supplier contracts	8,300		8,300		12,900
Accrued commission on sale or lease of the theater systems payable in future periods	1,900		1,900		1,300
Bank of Montreal Facilities [Member]
Commitments (Additional Textuals)
Outstanding letter of credit and advance payment guarantees secured	900		900		800
Credit Facililty [Member]
Commitments (Additional Textuals)
Outstanding letter of credit and advance payment guarantees secured	$ 0		$ 0		$ 3,000

Contingencies and Guarantees (Details) - USD ($) $ in Thousands		1 Months Ended	9 Months Ended	12 Months Ended
	Jun. 01, 2003	Sep. 20, 2006	Sep. 30, 2012	Dec. 31, 2011	Jan. 26, 2012	Dec. 02, 2011	Mar. 16, 2011	Mar. 27, 2008	Aug. 24, 2007
Accrual for product warranties
Balance at the beginning of period			$ 94	$ 160
Warranty redemptions			(66)	(152)
Warranties issued			28	146
Warranty revisions			(48)	(60)
Balance at the end of period			8	94
Contingencies and Guarantees Disclosure (Textuals) [Abstract]
Interim awards issued in favor of Company									$ 9,400
Final Award in favor of company						$30,000 to cover the costs of the application		Amount of $11.3 million plus an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid
Damages sought	over 5.0 million	210,000,000
The arbitrator issued a final award in damages					$ 12,000		$ 400
Pre-judgment interest on claim for breach of one of the Ride film production agreements							300
Attorneys' fees and Attorneys' fee provision							$ 1,200
Indemnification of its directors/officers			$ 0	$ 0
Other Indemnification			0
Financial Guarantees			$ 0

Condensed Consolidated Statement of Operations Supplemental Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2012 USD ($)	Sep. 30, 2011 USD ($)	Sep. 30, 2012 USD ($)	Sep. 30, 2011 USD ($)
Selling Expenses
Deferred direct selling cost	$ 900,000	$ 600,000	$ 2,100,000	$ 1,400,000
Film exploitation costs, including advertising and marketing	500,000	800,000	3,400,000	3,600,000
Commissions recognized as cost and expenses	500,000	500,000	1,000,000	1,400,000
Direct advertising and marketing costs related to theater	600,000	800,000	1,100,000	2,100,000
Foreign Exchange
Foreign exchange translation gains (losses) related to monetary assets and liabilities and un hedged foreign exchange contracts	$ 300,000	(4,100,000)	$ 1,200,000	(3,500,000)
Collaborative Arrangements
Non-cancellable joint revenue sharing arrangements	7 to 10 years		7 to 10 years
Total number of exhibitors under joint revenue sharing agreements	28		28
Total number of theater systems under joint revenue sharing agreements	436		436
Total number of operating theaters under joint revenue sharing agreement	287		287
Amounts attributable to transactions arising between the company and its customers under joint revenue sharing arrangements	$ 13,200,000	10,000,000	$ 40,500,000	22,400,000
Percentage of the gross box-office receipts of the film, minimum for recovering digital re-mastering cost	10.00%		10.00%
Percentage of the gross box-office receipts of the film, maximum for recovering digital re-mastering cost	15.00%		15.00%
IMAX DMR films released in the current period			26
Number of films to be released in the Remainder of the current year			9
Amounts attributable to transactions arising between the company and its customers under IMAX DMR arrangements	$ 25,300,000	18,600,000	$ 58,800,000	38,300,000
Number of significant co-produced film arrangement	4		4
Share in total assets and liabilities balance in co-produced film arrangement	greater than 50%		greater than 50%
Total assets and liabilities of VIE	$ 14,800,000		$ 14,800,000
Number of other co-produced film arrangements	2		2
Amounts attributable to transactions between the company and other parties included in cost and expense	$ 1,500,000	$ 2,500,000	$ 4,700,000	$ 6,100,000

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Decrease (increase) in:
Accounts receivable	$ 9,915	$ (1,224)
Financing receivables	(4,900)	(8,471)
Inventories	(4,169)	(5,274)
Prepaid expenses	(955)	(1,548)
Commissions and other deferred selling expenses	113	(44)
Insurance recoveries	138	1,202
Other assets	(1,313)	(1,659)
Increase (decrease) in:
Accounts payable	(11,174)	(6,376)
Accrued and other Liabilities	(1,528)	(31,027)
Deferred revenue	5,201	6,229
Changes in other non-cash operating assets and liabilities	(8,672)	(48,192)
Cash payments
Income taxes	977	2,201
Interest	$ 1,181	$ 878

Receivable Provisions Net of Recoveries (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Receivable Provisions, Net of Recoveries [Abstract]
Accounts receivable provisions, net of recoveries	$ 241	$ 163	$ 674	$ 433
Financing receivables, net of recoveries	0	245	155	334
Receivable provisions, net of recoveries	$ 241	$ 408	$ 829	$ 767

- Definition

The sum of the periodic provision charged to earnings, based on an assessment of uncollectibility from the counterparty on account of loan, lease or other credit losses, to reduce these accounts to the amount that approximates their net realizable value.

+ References + Details

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Income Tax Effect on Comprehensive Income
Amortization of actuarial loss on defined benefit plan	$ (23)	$ (13)	$ (69)	$ (40)
Unrealized change in cash flow hedging instruments	(153)	344	(213)	248
Realization of cash flow hedging gains upon settlement	42	21	7	219
Change in market value of available-for-sale investment	0	0	(42)	61
Other-than-temporary impairment of available-for-sale investment	0	0	(19)	0
Income tax effect on comprehensive income (loss)	$ (134)	$ 352	$ (336)	$ 488

- Definition

Tax effect of the income statement impact of the reclassification adjustment of accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges realized in net income. Also includes reclassification adjustments of an entity's share of an equity investee's deferred hedging gain (loss) realized in net income.

+ References + Details

- Definition

Tax effect of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=20435746&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e39076-109324

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 36
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Capital Stock (Details) - Employee Stock Option [Member]	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Weighted average fair value of common share granted to employees
Average risk-free interest rate	1.07%	2.35%	1.38%	2.79%
Expected volatility	50.00%	50.00%	50.00%	50.00%
Dividend yield	0.00%	0.00%	0.00%	0.00%
Maximum [Member]
Weighted average fair value of common share granted to employees
Expected option life (in years)	5 years 3 months 18 days	5 years 1 month 24 days	5 years 4 months 10 days	5 years 1 month 24 days
Annual termination probability	8.76%	8.31%	8.76%	8.49%
Minimum [Member]
Weighted average fair value of common share granted to employees
Expected option life (in years)	5 years 3 months 14 days	5 years 1 month 13 days	2 years 10 months 20 days	1 year 9 months 11 days
Annual termination probability	8.52%	0.00%	0.00%	0.00%

Segmented Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Segmented Information (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Revenues
Revenue	$ 80,711	$ 67,488	$ 206,517	$ 169,880
Gross margins
Gross margins	44,750	36,438	110,444	83,386
Assets
Total assets	427,035		427,035		$ 406,236
Imax Systems [Member]
Revenues
Revenue	25,358	20,649	59,063	63,378
Gross margins
Gross margins	15,956	13,294	34,475	36,469
Assets
Total assets	155,107		155,107		154,312
Theater System Maintenance [Member]
Revenues
Revenue	7,042	6,348	20,878	18,270
Gross margins
Gross margins	2,828	1,944	8,122	6,912
Assets
Total assets	13,376		13,376		13,008
Joint Revenue Sharing Arrangements [Member]
Revenues
Revenue	13,186	9,995	40,477	22,382
Gross margins
Gross margins	9,286	6,733	28,340	13,792
Assets
Total assets	123,404		123,404		120,483
Others [Member]
Revenues
Revenue	4,997	3,908	10,394	9,027
Gross margins
Gross margins	564	226	287	(357)
Assets
Total assets	3,095		3,095		2,718
Corporate And Other Non Segment Specific Assets [Member]
Assets
Total assets	110,624		110,624		90,449
Production and Imax Dmr [Member]
Revenues
Revenue	25,223	18,600	58,805	38,280
Gross margins
Gross margins	15,426	12,015	35,714	21,235
Assets
Total assets	10,628		10,628		16,577
Distribution [Member]
Revenues
Revenue	3,259	4,965	11,122	12,857
Gross margins
Gross margins	587	1,418	2,133	2,531
Assets
Total assets	6,737		6,737		4,504
Post Production [Member]
Revenues
Revenue	1,646	3,023	5,778	5,686
Gross margins
Gross margins	103	$ 808	1,373	$ 2,804
Assets
Total assets	$ 4,064		$ 4,064		$ 4,185

Employees Pension and Postretirement Benefits (Details) - Pension Plans, Defined Benefit [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Amounts Accrued
Obligation, beginning of period			$ 18,990	$ 18,108	$ 18,108
Interest cost	$ 68	$ 69	204	209	279
Actuarial loss			0		603
Obligation, end of period and unfunded status	19,194		19,194		18,990
Pension Expense
Interest cost	68	69	204	209	279
Amortization of actuarial loss	91	53	273	161
Pension expense	159	$ 122	477	$ 370
Components of net periodic benefit cost
Unrecognized actuarial loss	$ 2,355		$ 2,355		$ 2,628

Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Other Financial Instrument
Net financed sales receivable	$ 78,211	$ 67,300
Net investment in sales-type leases	13,322	19,414
Carrying (Reported) Amount, Fair Value Disclosure [Member]
Other Financial Instrument
Borrowings under Credit Facility	(30,000)	(55,083)
Net financed sales receivable	78,211	67,300
Net investment in sales-type leases	13,322	19,414
Available-for-sale investment	1,350	1,012
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| Designated as Hedging Instrument [Member]
Other Financial Instrument
Foreign exchange contracts	621	(182)
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| Not Designated as Hedging Instrument [Member]
Other Financial Instrument
Foreign exchange contracts	345	(645)
Estimate of Fair Value, Fair Value Disclosure [Member]
Other Financial Instrument
Borrowings under Credit Facility	(30,000)	(55,083)
Net financed sales receivable	75,925	65,846
Net investment in sales-type leases	13,730	20,448
Available-for-sale investment	1,350	1,012
Estimate of Fair Value, Fair Value Disclosure [Member] \| Designated as Hedging Instrument [Member]
Other Financial Instrument
Foreign exchange contracts	621	(182)
Estimate of Fair Value, Fair Value Disclosure [Member] \| Not Designated as Hedging Instrument [Member]
Other Financial Instrument
Foreign exchange contracts	$ 345	$ (645)

Property Plant and Equipment (Details Textual) - USD ($) $ in Millions	Sep. 30, 2012	Dec. 31, 2011
Property, Plant and Equipment (Textuals) [Abstract]
Equipment leased or held for use, Gross	$ 11.2	$ 18.4
Accumulated Depreciation, equipment leased or held for use	10.1	17.8
Assets under joint revenue sharing arrangements included in Theater system components	111.1	100.2
Accumulated Depreciation , Assets under joint revenue sharing arrangements included in Theater system components	26.5	19.1
Assets under joint revenue sharing arrangements included in Assets under construction	$ 6.8	$ 3.7

Credit Facility (Details 1) $ in Thousands	Sep. 30, 2012 USD ($)
Term loan principal payments
2012 (three months remaining)	$ 0
2013	0
2014	0
2015	30,000
2016	0
Thereafter	0
Term Loan [Member]
Term loan principal payments
Debt under revolving credit facility	$ 30,000

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details 1) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Summary of Depreciation and amortization
Film assets	$ 12,131	$ 9,373
Other intangible assets	1,507	341
Other assets	368	181
Deferred financing costs	128	345
Property, plant and equipment
Joint revenue sharing arrangements	7,384	4,914
Other property, plant and equipment	3,186	2,866
Depreciation and amortization	$ 24,704	$ 18,020

- Definition

The other noncash expense, not otherwise specified in the taxonomy, charged against earnings in the period to allocate the cost of tangible and intangible assets over their remaining economic lives.

+ References + Details

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details 2) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Asset Impairments
Accounts receivable			$ 674	$ 433
Financing receivables			155	334
Inventories			503	0
Impairment of available-for-sale investment	$ 0	$ 0	150	0
Property, plant and equipment			18	74
Other intangible assets			11	0
Other assets			5	0
Write-downs, net of recoveries			$ 1,516	$ 841

- Definition

Charge to cost of goods sold that represents the reduction of the carrying amount of inventory, generally attributable to obsolescence or market conditions.

+ References + Details

Condensed Consolidated Statements of Cash Flows Supplemental Information (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Inventory Charges
Recorded in costs and expenses applicable to revenues - services	$ 200	$ 0
Condensed Consolidated Statements of Cash Flows Supplemental Information (Textuals) [Abstract]
Payments for variable stock based compensation	300	23,700
Film Based Projector [Member]
Inventory Charges
Recorded in costs and expenses applicable to revenues - product and equipment sales	$ 300	$ 0

Income Taxes (Details Textual) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
Income Taxes (Details Textual) - USD ($) $ in Millions	Sep. 30, 2012	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Deferred Tax Assets
Deferred income tax after valuation allowance	$ 40.2	$ 40.2		$ 50.0
Deferred income tax before valuation allowance	46.3	46.3		56.1
Valuation allowance	6.1	6.1		6.1
Deferred tax asset increase and deferred tax provision decrease due to a change in enacted tax rates		0.7
Total unrecognized tax benefit Including interest and penalties	4.8	4.8		$ 4.4
Interest and penalty associated with unrecognized tax benefits	$ 0.1	$ 0.2	$ 0.2
Interest and penalty associated with unrecognized tax benefits	less than $0.1

Capital Stock (Details 1) - Employee Stock Option [Member] - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Option activity under the Stock Option Plan
Options outstanding, beginning of year				6,743,272
Options outstanding, per share beginning of year				$ 10.79
Options granted			1,686,862	1,122,342
Weighted average fair value of options granted			$ 24.78	$ 31.79
Exercised			(924,579)	(528,485)
Weighted average fair value of options exercised			$ 6.31	$ 10.66
Forfeited			(154,958)	(141,600)
Weighted average fair value of options forfeited			$ 23.03	$ 19.68
Expired			0	0
Weighted average fair value of options expired			$ 0	$ 0
Options cancelled	(3,820)	0	(4,120)	0
Weighted average fair value of options cancelled			$ 33.73	$ 0
Options outstanding, end of period	7,803,926	7,195,529	7,803,926	7,195,529
Options outstanding, per share end of period	$ 17.61	$ 13.90	$ 17.61	$ 13.90
Options exercisable, end of period	3,706,631	3,607,049	3,706,631	3,607,049
Options exercisable, weighted average exercise price	$ 13.80	$ 9.19	$ 13.80	$ 9.19

Capital Stock (Details 2) - Options Non Employees [Member]	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Options to Non-Employees
Average risk-free interest rate	1.28%	2.38%
Contractual option life (in years)	7 years	6 years
Expected volatility	50.00%	50.00%
Dividend yield	0.00%	0.00%

Capital Stock (Details 3) - Stock Appreciation Rights [Member]	9 Months Ended	12 Months Ended
	Sep. 30, 2012	Dec. 31, 2011
Fair value measurement of stock appreciation rights
Average risk-free interest rate	0.62%	1.09%
Expected volatility	50.00%	50.00%
Annual termination probability	8.76%	8.76%
Dividend yield	0.00%	0.00%
Maximum [Member]
Fair value measurement of stock appreciation rights
Expected option life (in years)	2 years 9 months 7 days	3 years 5 months 16 days
Minimum [Member]
Fair value measurement of stock appreciation rights
Expected option life (in years)	2 years 8 months 8 days	3 years 2 months 5 days

Capital Stock (Details 4) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Capital Stock (Details 4) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Basic and diluted per-share computations
Net income from operations applicable to common shareholders	$ 14,990	$ 8,392	$ 28,658	$ 9,214
Weighted average number of common shares (000's):
Issued and outstanding, beginning of period	65,977,319		65,977,319		65,893,000	65,052,740	64,568,000	64,146,000
Weighted average number of shares issued during the period	37,000	86,000	665,000	260,000
Weighted average number of shares used in computing basic income per share	65,930,000	64,654,000	65,718,000	64,406,000
Assumed exercise of stock options, net of shares assumed	2,371,000	3,102,000	2,469,000	3,704,000
Weighted average number of shares used in computing diluted income (loss) per share	68,301,000	67,756,000	68,187,000	68,110,000

- Definition

Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4613673-111683

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph b(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References + Details

- Definition

This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e2646-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 07-4
-Paragraph 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 171
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 128
-Paragraph 40
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Capital Stock (Details 5) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Capital Stock (Details 5) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Movement of Shareholders Equity
Issuance of common shares for stock options exercised			$ 5,831
Net income	$ 14,990	$ 8,392	28,658	$ 9,214
Adjustment to other equity for employee stock options granted			9,841
Adjustment to other equity for non-employee stock options granted			115
Adjustment to capital stock for stock options exercised			879
Adjustment to other equity for stock options exercised			(879)
Adjustments to accumulated other comprehensive loss for unrealized gain from cash flow hedging instruments			826
Adjustments to accumulated other comprehensive loss for the realization of cash flow hedging net gain upon settlement			(22)
Adjustments to accumulated other comprehensive loss for the amortization of actuarial loss on defined benefit plan	91	53	273	161
Adjustment to accumulated other comprehensive loss for a change in market value of available-for-sale investment	0	0	338	(488)
Adjustment to accumulated other comprehensive loss for an other-than-temporary impairment of available-for-sale investment	0	0	150	0
Tax effect of movement in comprehensive income (loss)	134	$ (352)	336	$ (488)
Balance as at September 30, 2012	$ 238,581		$ 238,581

Capital Stock (Details Textual) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011	Dec. 31, 2007	Dec. 31, 2010	Jul. 12, 2000
Capital Stock (Textuals) [Abstract]
Share-based compensation costs (recovery) recorded	$ 2.8	$ 0.5	$ 10.3	$ 9.2
Employee Stock Option [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs (recovery) recorded	$ 3.2	$ 2.4	$ 9.8	$ 7.2
Reserved common shares for future issuance	13,195,464		13,195,464		13,010,548
Options outstanding	7,803,926	7,195,529	7,803,926	7,195,529	7,200,721		6,743,272
Options outstanding, weighted average exercise price	$ 17.61	$ 13.90	$ 17.61	$ 13.90	$ 14.60		$ 10.79
Options fully vested or expected to vest, weighted average exercise price	$ 16.98		$ 16.98
Options common shares were vested and exercisable	3,706,631		3,706,631
Options fully vested, expected	7,000,018		7,000,018
Options fully vested or expected to vest, weighted average remaining contractual life			5 years
Options fully vested or expected to vest, aggregate intrinsic value	$ 41.8		$ 41.8
Weighted average remaining contractual life of exercisable option			4 years 6 months
Options exercisable intrinsic value	31.7		$ 31.7
Intrinsic value of options exercised	$ 1.0	$ 2.4	$ 15.3	$ 11.2
Options granted			1,686,862	1,122,342
Options exercisable	3,706,631	3,607,049	3,706,631	3,607,049
Options exercisable, weighted average exercise price	$ 13.80	$ 9.19	$ 13.80	$ 9.19
Weighted average fair value of options granted	$ 6.93	$ 9.04	$ 7.49	$ 9.59
Options forfeited	0	0	0	0
Options cancelled	3,820	0	4,120	0
Options Non Employees [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period		$ 0.1	$ 0.1	$ 0.8
Share-based compensation costs recorded	less than $100,000
Options outstanding	120,001	142,251	120,001	142,251
Options outstanding, weighted average exercise price	$ 14.14	$ 12.93	$ 14.14	$ 12.93
Options fully vested or expected to vest, aggregate intrinsic value	$ 0.3	$ 0.2	$ 0.3	$ 0.2
Options granted	0	0	12,500	103,944
Options granted to purchase the company's common stock, average exercise price	$ 0	$ 0	$ 22.82	$ 27.64
Common share options subject to vesting based on performance commitment value			$ 0.1
Number of options modified in the period					15,000
Options exercisable	34,717	49,750	34,717	49,750
Options exercisable, weighted average exercise price	$ 11.59	$ 11.51	$ 11.59	$ 11.51
Weighted average fair value of options granted			$ 11.73	$ 13.75
Amount of stock options or rights included in accrued liabilities	less than $0.1		less than $0.1
Amount of stock options or rights included in accrued liabilities					$ 0.1
Restricted Stock [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs charged for the period	$ 0.0	$ 0.0	$ 0.0	$ 0.0
Restricted common shares required to be issued under employment agreements								0
Cash paid in settlement					0.0
Stock Appreciation Rights [Member]
Capital Stock (Textuals) [Abstract]
Share-based compensation costs (recovery) recorded	$ (0.4)	$ (2.0)	$ 0.3	$ 1.2
Weighted average remaining contractual life of exercisable option			5 years 3 months
Weighted average fair value of options granted						$ 6.20
Options forfeited	0	0	0	0
Amount of stock options or rights included in accrued liabilities	$ 1.6		$ 1.6		$ 1.6
Cash paid in settlement	$ 0.0	$ 0.0	$ 0.3	$ 23.7
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number	118,000		118,000
Number of rights settled in cash	0	0	15,000	999,500
Stock appreciation rights granted			0	0		2,280,000
Average exercise price of cash settled rights	$ 0.0	$ 0.0	$ 6.86	$ 6.86
Share based compensation arrangement by share based payment award equity instruments other than options exercisable	100,000		100,000
Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, weighted average grant date fair value	$ 13.82		$ 13.82		$ 12.43
Warrants [Member]
Capital Stock (Textuals) [Abstract]
Warrants issued or outstanding	0	0	0	0
Maximum [Member] \| Employee Stock Option [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			5 years
Stock based awards expiration period or remaining contractual life			Aug. 19, 2019
Maximum [Member] \| Options Non Employees [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			5 years
Stock based awards expiration period or remaining contractual life			May 14, 2019
Maximum [Member] \| Stock Appreciation Rights [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			5 years
Minimum [Member] \| Employee Stock Option [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			1 year
Stock based awards expiration period or remaining contractual life			Oct. 01, 2012
Minimum [Member] \| Options Non Employees [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			1 year
Stock based awards expiration period or remaining contractual life			Oct. 01, 2012
Minimum [Member] \| Stock Appreciation Rights [Member]
Capital Stock (Textuals) [Abstract]
Stock based awards vesting period			0 years

Segmented Information (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Segmented Information (Details 1) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Geographical Information
Geographical Information, Domestic	$ 38,897	$ 30,030	$ 98,007	$ 82,713
Total	80,711	67,488	206,517	169,880
Asia excluding greater China [Member]
Geographical Information
Geographical Information, foreign	8,822	6,252	18,687	13,735
Russia and Cis [Member]
Geographical Information
Geographical Information, foreign	7,994	2,804	14,615	13,620
Greater China [Member]
Geographical Information
Geographical Information, foreign	7,567	7,949	29,002	17,893
Rest of world [Member]
Geographical Information
Geographical Information, foreign	5,212	6,281	13,778	9,074
Western Europe [Member]
Geographical Information
Geographical Information, foreign	4,426	6,078	15,201	14,758
Canada [Member]
Geographical Information
Geographical Information, foreign	6,357	6,846	14,289	13,314
Rest of Europe [Member]
Geographical Information
Geographical Information, foreign	775	626	1,396	3,334
Mexico [Member]
Geographical Information
Geographical Information, foreign	$ 661	$ 622	$ 1,542	$ 1,439

Segmented Information (Details Textual) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Segment Reporting (Textuals) [Abstract]
Commission Costs	$ 0.9	$ 0.6	$ 2.1	$ 1.4
Disclosure on Geographic Areas, Description of Revenue from External Customers			No single country in the Rest of the World, Western Europe, Rest of Europe or Asia (excluding Greater China) classifications comprise more than 5% of the total revenue.
Percentage of total revenues represented by two largest customers	15.00%	17.30%	16.50%	17.80%
Imax Systems [Member]
Segment Reporting (Textuals) [Abstract]
Commission Costs	$ 0.9	$ 0.6	$ 2.1	$ 1.4
Joint Revenue Sharing Arrangements [Member]
Segment Reporting (Textuals) [Abstract]
Advertising, marketing and commission costs	1.1	1.3	2.1	3.6
Production and Imax Dmr [Member]
Segment Reporting (Textuals) [Abstract]
Marketing Expense	$ 0.5	0.7	2.2	1.9
Distribution [Member]
Segment Reporting (Textuals) [Abstract]
Marketing Expense		$ 0.1	$ 1.2	$ 1.7
Marketing Expense (Recovery)	less than ($0.1)

Employees Pension and Postretirement Benefits (Details 1) $ in Thousands	Sep. 30, 2012 USD ($)
Pension Plans, Defined Benefit [Member]
Schedule of expected benefit payments
2012 (three months remaining):	$ 0
2013	0
2014	19,676
2015	0
2016	0
Thereafter	0
Total expected future benefit payment	19,676
Other Postretirement Benefit Plans, Defined Benefit [Member]
Schedule of expected benefit payments
2012 (three months remaining):	15
2013	16
2014	35
2015	38
2016	42
Thereafter	407
Total expected future benefit payment	$ 553

Employees Pension and Postretirement Benefits (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Jan. 01, 2012	Dec. 31, 2011	Dec. 31, 2010	Jul. 31, 2000
Employees Pension and Postretirement Benefits (Additional Textuals) [Abstract]
Defined benefit pension plan			The Company has an unfunded U.S. defined benefit pension plan (the “SERP”) covering Richard L. Gelfond, Chief Executive Officer (“CEO”) of the Company and Bradley J. Wechsler, Chairman of the Company’s Board of Directors. The SERP provides for a lifetime retirement benefit from age 55 determined as 75% of the member’s best average 60 consecutive months of earnings over the member’s employment history. The benefits were 50% vested as at July 2000, the SERP initiation date. The vesting percentage increases on a straight-line basis from inception until age 55. As at September 30, 2012, the benefits of Mr. Gelfond were 100% vested. Upon a termination for cause, prior to a change of control, the executive shall forfeit any and all benefits to which such executive may have been entitled, whether or not vested.
Description Of Defined Contribution Pension And Other Postretirement Plans			The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums.
Percentage of benefits vested since plan inception date								50.00%
Maximum percentage of base salary contributed to Pension Plan by Company			5.00%
Termination Benefit Vested	100.00%		100.00%
Pension Plans, Defined Benefit [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Amortization of actuarial losses			$ 100
Postretirement benefits obligation	$ 19,194		19,194		$ 18,990	$ 18,990	$ 18,108
Expected interest costs in the remainder of the year			100
Future amortization of actuarial loss			100
Other Postretirement Benefit Plans, Defined Benefit [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Postretirement benefits obligation	$ 600		600			$ 500
Maximum amount of Postretirement benefit expensed	less than 100	less than 100
Companies contribution and expenses			100
Companies contribution and expenses				less than 100
Canadian Plan [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Companies contribution and expenses	$ 300	$ 200	800	$ 700
Us Internal Revenue Code [Member]
Pension and Other Postretirement Benefit Expense (Textuals) [Abstract]
Companies contribution and expenses			$ 200	$ 100
Companies contribution and expenses	less than 100	less than 100

Financial Instruments (Details 1) - USD ($) $ in Thousands	9 Months Ended
Financial Instruments (Details 1) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011
Summary of changes in the fair value
Beginning balance, January 1		$ 1,500
Transfers into/out of Level 3	$ 0	0
Total gains or losses (realized/unrealized) Included in earnings	In the nine months ended September 30, 2012, the Company recognized a $0.2 million other-than-temporary impairment of its available-for-sale investment, in “Impairment of available-for-sale investment” in the condensed consolidated statement of operations, as the value is not expected to recover based on the length of time and extent to which the market value has been less than cost.
Total gains or losses (realized/unrealized) Included in other comprehensive income	$ 338	(488)
Ending balance, September 30	1,350	1,012
The amount of total gains or losses for the period included in earnings attributable change in to the unrealized gains or losses relating to assets still held at the reporting date	$ (150)	$ 0

Financial Instruments (Details 2) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	$ 14,452	$ 21,247
Financed Sales Receivables	78,277	67,616
Total	92,729	88,863
In Good Standing [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	11,318	15,667
Financed Sales Receivables	70,027	55,907
Total	81,345	71,574
Credit Watch Member [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	187	1,506
Financed Sales Receivables	7,272	3,718
Total	7,459	5,224
Pre-Approved Transactions [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	783	1,837
Financed Sales Receivables	296	7,272
Total	1,079	9,109
Transactions Suspended [Member]
Recorded investment in financing receivables by credit quality indicator
Minimum Lease Payments	2,164	2,237
Financed Sales Receivables	682	719
Total	$ 2,846	$ 2,956

Financial Instruments (Details 3) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Investment In Financing Receivables On Nonaccrual Status
Net investment in leases recorded investment	$ 2,947	$ 4,692
Net investment in leases related allowance	(1,130)	(1,833)
Net financed sales receivables recorded investment	978	1,329
Net financed sales receivables related allowance	(66)	(316)
Total recorded investment	3,925	6,021
Total related allowance	$ (1,196)	$ (2,149)

Financial Instruments (Details 4) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	$ 1,333	$ 1,073
30-89 Days	644	854
90+ Days	2,180	2,783
Billed Financing Receivables	4,157	4,710
Related Unbilled Recorded Investment	88,572	84,152
Total Recorded Investment	92,729	88,863
Related Allowances	(1,196)	(2,149)
Recorded Investment Net of Allowances	91,533	86,714
Net Financed Sales Receivables [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	1,125	723
30-89 Days	549	593
90+ Days	1,037	1,029
Billed Financing Receivables	2,711	2,345
Related Unbilled Recorded Investment	75,566	65,270
Total Recorded Investment	78,277	67,616
Related Allowances	(66)	(316)
Recorded Investment Net of Allowances	78,211	67,300
Net Investment in Leases [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	208	350
30-89 Days	95	261
90+ Days	1,143	1,754
Billed Financing Receivables	1,446	2,365
Related Unbilled Recorded Investment	13,006	18,882
Total Recorded Investment	14,452	21,247
Related Allowances	(1,130)	(1,833)
Recorded Investment Net of Allowances	13,322	19,414
Financing Receivables Continue To Accrue Finance Income [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	246	269
30-89 Days	328	463
90+ Days	670	818
Billed Financing Receivables	1,244	1,550
Related Unbilled Recorded Investment	15,429	20,109
Related Allowances	0	0
Recorded Investment Net of Allowances	16,673	21,659
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Financed Sales Receivables [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	239	202
30-89 Days	314	345
90+ Days	649	674
Billed Financing Receivables	1,202	1,221
Related Unbilled Recorded Investment	15,284	16,343
Related Allowances	0	0
Recorded Investment Net of Allowances	16,486	17,564
Financing Receivables Continue To Accrue Finance Income [Member] \| Net Investment in Leases [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	7	67
30-89 Days	14	118
90+ Days	21	144
Billed Financing Receivables	42	329
Related Unbilled Recorded Investment	145	3,766
Related Allowances	0	0
Recorded Investment Net of Allowances	$ 187	$ 4,095

Financial Instruments (Details 5) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Financial Instruments (Details 5) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Financing Receivable, Impaired [Line Items]
Related Allowance	$ (66)	$ (66)	$ (66)	$ (66)
Net Financed Sales Receivables [Member]
Financing Receivable, Impaired [Line Items]
Impaired Financing Receivable with Related Allowance, Recorded Investment	671	225	671	225
Impaired Financing Receivable With Related Allowance, Unpaid Principal	195	208	195	208
Impaired Financing Receivable With Related Allowance, Average Recorded Investment	671	227	204	235
Impaired Financing Receivable With Related Allowance, Interest Income Recognized	0	0	0	0
Impaired Financing Receivable With No Related Allowance, Unpaid Principal	19		19
Impaired Financing Receivable With No Related Allowance, Average Recorded Investment	474		512
Impaired Financing Receivable With No Related Allowance, Recorded Investment	385		385
Impaired Financing Receivable With No Related Allowance, Interest Income Recognized	(11)		(11)
Unpaid Principal	214	208	214	208
Average Recorded Investment	1,145	227	716	235
Related Allowance	(66)	(66)	(66)	(66)
Recorded Investment	1,056	225	1,056	225
Interest Income Recognized	$ (11)	$ 0	$ (11)	$ 0

Financial Instruments (Detail 6) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Financial Instruments (Detail 6) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Allowance for credit losses:
Ending balance	$ 1,196		$ 1,196
Net Financed Sales Receivables [Member]
Allowance for credit losses:
Beginning balance	173	$ 66		$ 66
Charge-offs	(107)	0	(109)	0
Provision	0	0	(141)	0
Ending balance	66	66	66	66
Ending balance: individually evaluated for impairment	66	66	66	66
Financing receivables:
Ending balance: individually evaluated for impairment	78,277	61,939	78,277	61,939
Net Investment in Leases [Member]
Allowance for credit losses:
Beginning balance	1,892	2,592		4,838
Charge-offs	(762)	(363)	(1,019)	(2,808)
Provision	0	320	316	519
Ending balance	1,130	2,549	1,130	2,549
Ending balance: individually evaluated for impairment	1,130	2,549	1,130	2,549
Financing receivables:
Ending balance: individually evaluated for impairment	$ 14,452	$ 22,000	$ 14,452	$ 22,000

Financial Instruments (Details 7) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Derivatives Fair Value [Line Items]
Derivative asset, Notional amount	$ 20,774	$ 87,922
Foreign Exchange Contract [Member] \| Designated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Derivative asset, Notional amount	13,500	20,581
Foreign Exchange Contract [Member] \| Not Designated as Hedging Instrument [Member]
Derivatives Fair Value [Line Items]
Derivative asset, Notional amount	$ 7,274	$ 67,341

Financial Instruments (Details 8) - USD ($) $ in Thousands	Sep. 30, 2012	Dec. 31, 2011
Fair value of foreign exchange contracts
Derivative Asset, Fair Value	$ 966	$ 827
Other Assets [Member] \| Foreign Exchange Forward [Member] \| Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Asset, Fair Value	621
Other Assets [Member] \| Foreign Exchange Forward [Member] \| Not Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Asset, Fair Value	$ 345
Accrued Liabilities [Member] \| Foreign Exchange Forward [Member] \| Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Asset, Fair Value		182
Accrued Liabilities [Member] \| Foreign Exchange Forward [Member] \| Not Designated as Hedging Instrument [Member]
Fair value of foreign exchange contracts
Derivative Asset, Fair Value		$ 645

Financial Instruments (Details 9) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Financial Instruments (Details 9) - USD ($) $ in Thousands	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Derivatives in Foreign Currency Hedging relationships
Adjustments to accumulated other comprehensive income to record unrealized hedging (loss) gain	$ 589	$ (1,151)	$ 826	$ (800)
Realization of hedging gains (losses) upon settlement	158	229	22	953
Non Designated Derivatives in Foreign Currency relationships
Derivative (loss) gain	400	(3,893)	1,229	(3,172)
Fair Value Hedging [Member]
Derivatives in Foreign Currency Hedging relationships
Adjustments to accumulated other comprehensive income to record unrealized hedging (loss) gain	589	(1,151)	826	(800)
Foreign Exchange Forward [Member] \| Selling General And Administrative Expenses [Member]
Non Designated Derivatives in Foreign Currency relationships
Derivative (loss) gain	400	(3,893)	1,229	(3,172)
Foreign Exchange Forward [Member] \| Fair Value Hedging [Member] \| Selling General And Administrative Expenses [Member]
Derivatives in Foreign Currency Hedging relationships
Realization of hedging gains (losses) upon settlement	$ 158	$ 229	$ 22	$ 953

Financial Instruments (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Financial Instruments Additional (Textuals) [Abstract]
Carrying value of equity investments	$ 3,400		$ 3,400		$ 4,100
Investment in preferred stock of other business venture	1,300		$ 1,300		1,000
Financial Instruments (Textuals) [Abstract]
Financing receivables indications of theaters with potential collection concerns			60-89 days
Gross revenues of investment new business ventures	2,700	$ 700	$ 6,500	$ 1,200
Cost of revenue of investment new business ventures	2,900	2,700	8,900	6,500
Net loss on equity-accounted investments	3,000	4,300	9,900	12,900
Equity method investment, difference between carrying amount and underlying equity	1,300		$ 1,300
Total gains or losses (realized/unrealized) Included in earnings			In the nine months ended September 30, 2012, the Company recognized a $0.2 million other-than-temporary impairment of its available-for-sale investment, in “Impairment of available-for-sale investment” in the condensed consolidated statement of operations, as the value is not expected to recover based on the length of time and extent to which the market value has been less than cost.
Cost of available for sale securities	1,500		$ 1,500		1,500
Fair value of debt	1,300		1,300		1,000
Impairment of available-for-sale investment	0	$ 0	150	$ 0
Total carrying value of investments in new business ventures	4,700		4,700		5,100
Troubled debt restructuring write-down			100
Troubled debt restructuring recorded investment	500		500
Variable Interest Entity, Not Primary Beneficiary [Member]
Financial Instruments Additional (Textuals) [Abstract]
Carrying value of equity investments	$ 3,400		$ 3,400		$ 4,100

Label	Element	Value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	$ 1,012,000
Net Financed Sales Receivables [Member]
Financing Receivable, Allowance for Credit Losses	us-gaap_FinancingReceivableAllowanceForCreditLosses	316,000
Finance Leases Financing Receivable [Member]
Financing Receivable, Allowance for Credit Losses	us-gaap_FinancingReceivableAllowanceForCreditLosses	$ 1,833,000